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MISUSE OF MISUSE: PRINCO CORP. V. INTERNATIONAL TRADE
COMMISSION AND THE FEDERAL CIRCUIT'S MISGUIDED PATENT
MISUSE JURISPRUDENCE
Saami Zain*
The equitable doctrine of patent misuse is best known for
prohibiting patentees from exploiting the rights and benefits that
arise from the grant of a patent. Despite a long history of
favorable Supreme Court cases, over the past twenty-five years the
U.S. Court of Appeals for the Federal Circuit has substantially
narrowed the patent misuse doctrine. Most recently, in Princo
Corp. v. International Trade Commission, the Federal Circuit
seems to have further curtailed the doctrine by suggesting that
additional, burdensome requirements may be necessary for a
successful misuse defense. Specifically, the Princo decision seems
to impose a stringent evidentiary burden on those asserting misuse,
including demonstrating a direct and substantial nexus between
the challenged conduct and the asserted anticompetitive effects,
and intimating a higher threshold for proving anticompetitive
effects. The opinion also further entangles patent misuse
jurisprudence with antitrust concepts. The Federal Circuit's
Princo decision is not only inconsistent with Supreme Court
precedent, but also substantially hinders the policy goals of
preventing inequitable, abusive, and anticompetitive conduct by
patent holders. Rather than weakening it, the Federal Circuit
should focus on creating a better-defined, vigorous misuse
doctrine, independent of antitrust principles, to uphold these
worthy goals.
J.D., L.L.M (Antitrust). Assistant Attorney General, Antitrust Bureau, New
York State Office of the Attorney General. The views expressed here are those
of the author and do not reflect those of the New York State Department of Law,
the New York State Attorney General's Office, or the Antitrust Bureau.
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1. INTRODUCTION
The doctrine of patent misuse is an equitable defense that
proscribes certain conduct by patentees that is inconsistent with the
goals and policies underlying patent law. Patent misuse thereby
prohibits patentees from leveraging rights and benefits obtained
from their patent(s) to adversely affect competition in other
markets or in a manner that otherwise improperly exploits those
rights or benefits. The doctrine has a long and rich history.
Nevertheless, misuse has been criticized as being too vague and
lacking coherence in both application and policy, as well as
unfairly providing a windfall to infringing parties. Moreover,
because misuse is often pled alongside an antitrust counterclaim,
the two doctrines have become somewhat conjoined.
Consequently, some have argued that misuse has become
superfluous and should be subsumed by antitrust law, or even
abandoned entirely.
The U.S. Court of Appeals for the Federal Circuit, which has
exclusive appellate jurisdiction over patent cases, has been critical
of misuse for many years. In a line of cases spanning over twenty-
five years, it has substantially narrowed the doctrine while at the
same time further entangling misuse with antitrust. For example,
Federal Circuit cases have long required that a successful misuse
defense prove anticompetitive effects resulting from the challenged
conduct. In Princo Corp. v. International Trade Commission,' the
Federal Circuit's most recent patent misuse case, the Court further
curtailed the doctrine. First, the opinion appears to establish an
extremely high threshold for demonstrating anticompetitive
effects. Second, it suggests that a successful misuse defense may
require a direct and substantial nexus between the challenged
conduct and the asserted anticompetitive effects. This article
criticizes the Federal Circuit's misuse jurisprudence, up to and
including Princo, as unsupported by Supreme Court precedent and
as bad policy. The article not only questions the substantial
evidentiary burdens Princo seems to impose on misuse claims, but
also contends that Federal Circuit misuse cases have improperly
incorporated antitrust principles into misuse. Part II provides a
' 616 F.3d 1318 (Fed. Cir. 2010).
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background on the misuse doctrine, including a summary of the
major Supreme Court and Federal Circuit cases. Part III
summarizes the Princo case. Part IV provides an analysis of the
Princo decision and its potential implications. Finally, Part V
provides a short conclusion.
II. BACKGROUND
Patent misuse is an equitable doctrine that arose during the
early twentieth century in response to conduct involving patents
that courts found to be either anticompetitive, inequitable, and/or
inconsistent with patent law's underlying policies and privileges.
Although misuse lacks a specific and precise definition, it is
typically referred to as conduct that impermissibly extends beyond
the scope of the patent.2 Patent misuse arose out of the "unclean
hands" common law doctrine and was based on the policy that a
patentee should not be able to abuse privileges conferred by a
patent, or otherwise improperly obtain benefits not within the
scope of the patent grant.' It is an affirmative defense and does not
permit damages.! Rather, the typical remedy for misuse is that the
courts will not enforce a patent until the misuse has been
"purged."'
2 Morton Salt Co. v. G. S. Suppiger Co., 314 U.S. 488, 492 (1942) ("[T]he
public policy which includes inventions within the granted monopoly excludes
from it all that is not embraced in the invention. It equally forbids the use of the
patent to secure an exclusive right or limited monopoly not granted by the Patent
Office and which is contrary to public policy to grant."); Motion Picture Patents
Co. v. Universal Film Mfg. Co., 243 U.S. 502, 510 (1917) (invalidating a
restriction that was not within the scope of the patent); ROGER E. SCHECHTER &
JOHN R. THOMAS, INTELLECTUAL PROPERTY: THE LAW OF COPYRIGHTS,
PATENTS AND TRADEMARKS 505-08 (1st ed. 2003).
Morton Salt, 314 U.S. at 492 (noting that a patent is a special privilege and
the exclusive rights it provides are limited by the public policy for its purpose).
4 HERBERT HOVENKAMP ET AL., IP AND ANTITRUST: AN ANALYSIS OF
ANTITRUST PRINCIPLES APPLIED TO INTELLECTUAL PROPERTY LAW 3-71 to -76
(2nd ed. 2001).
5 Morton Salt, 314 U.S. at 488; HOVENKAMP, supra note 4, at 3-71 to -72; 6
DONALD CHISUM, CHISUM ON PATENTS § 19.04 (2000).
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Conduct that has traditionally been found to constitute misuse
is often referred to as "misuse per se."6 This conduct includes
certain types of ties and exclusive dealing arrangements involving
patents, licenses restricting the use of competing goods, and
license provisions extending royalties beyond the term of the
patent. As misuse is a flexible, equitable doctrine, other types of
conduct have also been found to constitute misuse, including
certain patent pools and grant-back licenses.' As discussed infra,
in more recent years, courts have tended to more carefully
scrutinize practices that are not misuse per se, making it more
difficult to successfully assert a misuse defense.'
Over the years, courts evaluating misuse claims have
increasingly referenced and incorporated principles from antitrust
law into misuse. Antitrust is concerned primarily with protecting
unfettered competition in markets for the purpose of benefitting
consumers by lowering prices and/or increasing output, as well as
providing incentives to innovate.' Antitrust thereby proscribes
6 See CHISUM, supra note 5, at § 19.04[3] (listing various types of conduct
held to be misuse). According to Chisum, "[t]he three classic acts of misuse are
(1) requiring the purchase of unpatented goods for use with patented apparatus
or processes, (2) prohibiting production or sale of competing goods, and (3)
conditioning the granting of a license under one patent upon the acceptance of
another and different license." Id.
7 HOVENKAMP, supra note 4, at 3-23, -29, -34, -37 (listing acts of misuse);
CHISUM, supra note 5, at § 19.04[3] (listing acts of misuse); see also U.S. DEP'T
OF JUSTICE & FTC, ANTITRUST GUIDELINES FOR THE LICENSING OF
INTELLECTUAL PROPERTY § 5.5 (1995), available at http://www.justice.gov/atr/
public/ guidelines/0558.htm (discussing potential anticompetitive effects of
pooling arrangements).
8 See infra Part II.C.
9 N. Pac. Ry. Co. v. United States, 356 U.S. 1, 4 (1958) ("The Sherman Act
was designed to be a comprehensive charter of economic liberty aimed at
preserving free and unfettered competition as the rule of trade. It rests on the
premise that the unrestrained interaction of competitive forces will yield the best
allocation of our economic resources, the lowest prices, the highest quality and
the greatest material progress, while at the same time providing an environment
conducive to the preservation of our democratic political and social institutions.
But even were that premise open to question, the policy unequivocally laid
down by the Act is competition."); LAWRENCE A. SULLIVAN & WARREN S.
GRIMES, THE LAW OF ANTITRUST: AN INTEGRATED HANDBOOK § 1.5(b) (1st ed.
2000).
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conduct that harms, or is likely to harm, competition or the
competitive process. While antitrust and misuse share certain
policy goals (e.g., innovation, preventing abuses of patent power to
harm competition), their goals and concerns are not entirely
coextensive."o Nevertheless, it is not uncommon for defendants in
infringement actions to assert both antitrust and misuse claims. In
cases where both claims are asserted, courts have often either
applied the same analysis to both claims, or failed to clarify the
distinctions." This has had the unfortunate effect of bluffing the
distinction between antitrust and misuse, and, as a result, some
have claimed that these two areas of law have become "hopelessly
entangled." 2 In recent years, the relationship between the
doctrines has become even more intertwined with courts often
directly and explicitly applying antitrust principles and analysis to
misuse, causing some to argue that the two doctrines are, or should
10 Christina Bohannan, IP Misuse As Foreclosure, 96 IOWA L. REv. 475, 497-
500 (2011) (patent policy goals include incentives to innovate and provide
access to the public domain); Robin C. Feldman, The Insufficiency of Antitrust
Analysis for Patent Misuse, 55 HASTINGS L. J. 399, 436 (2003) ("[A]lthough
patents are designed to promote the public interest through the advancement of
science, the patent system creates negative effects as well. These include the
anticompetitive effects of increased prices and reduced supply. They also
include effects separate from anticompetitive effects, such as encouraging
wasteful and duplicative activities and creating disincentives to future inventors.
Limiting the time and scope of the patent grant serves to limit the detrimental
effects of the patent system. Thus, any test to determine whether a behavior
improperly extends these limits must be designed to reflect the concerns
embodied in these limits. Antitrust rules are unlikely to detect many of the types
of concerns embodied in limiting the patent grant."); Joe Potenza et al., Patent
Misuse-The Critical Balance, A Patent Lawyer's View, 15 FED. CIR. B. J. 69,
97-100 (2005) (discussing the different policies underlying antitrust versus
misuse).
" See, e.g., Mallinckrodt v. Medipart, 976 F.2d 700, 706 (Fed. Cir. 1992).
12 Feldman, supra note 10, at 399 (misuse has become "hopelessly entangled"
with antitrust); HOVENKAMP, supra note 4, at 3-2 ("In many cases a finding of
an antitrust violation has also occasioned a finding of misuse."); HOVENKAMP,
supra note 4, at § 21.3f (noting that much of tying law is confusing because it is
based on misuse and with little analysis); see also CHISUM, supra note 5, at
§ 19.04[2] (noting the complex relationship between misuse and antitrust).
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be, largely coterminous.13 Further confusing matters is how a
violation of one law will affect a finding of liability on the other.
Because misuse has been held to be broader than antitrust, conduct
found to be misuse does not necessarily amount to an antitrust
violation, whereas conduct that falls short of an antitrust violation
may nevertheless constitute misuse.14 As discussed infra," recent
case law, including Princo, will likely further exacerbate the
confusion.
A. Principle Supreme Court Cases
The misuse doctrine was first defined and established by the
Supreme Court in Morton Salt Co. v. G.S. Suppiger Co." Morton
13 USM Corp. v. SPS Techs., Inc., 694 F.2d 505, 512 (7th Cir. 1982)
(criticizing misuse and suggesting it is superfluous to antitrust); HOVENKAMP,
supra note 4, at 3-11 ("Generally speaking, patent misuse doctrine is largely
coextensive with antitrust doctrine.").
14 Morton Salt Co. v. G. S. Suppiger Co., 314 U.S. 488, 494 (1942); CHISUM,
supra note 5, at § 19.04[2]. But see C.R. Bard, Inc. v. M3 Sys., Inc., 157 F.3d
1340 (Fed. Cir. 1998) (upholding jury verdict on antitrust liability while
vacating a jury verdict on misuse).
1 See infra Part IV.D.
16 314 U.S. at 494. Prior to Morton Salt, the Supreme Court decided a handful
of cases that, although not based on misuse, referred to many of the same policy
considerations that were used by the Morton Salt court. The first of these was
Motion Picture Patents Co. v. Universal Film Manufacturing Co., 243 U.S. 502,
510 (1917), wherein the Court held as unenforceable various restrictions in
license agreements involving (and affixed to) patented motion picture machines.
Id. at 502. Included in the restrictions was a restriction that projectors could
only be used to display films covered by the patentee's separate film patents. Id.
at 503. The patentee sought to enforce that restriction even after the films'
patents expired. Id. at 518. Holding the restrictions invalid, the Court cited
policy justifications, noting that "the primary purpose of our patent laws is not
the creation of private fortunes for the owners of patents but is 'to promote the
progress of science and useful arts."' Id. at 511. Similarly, in Carbice Corp. of
America v. American Patents Development Corp., 283 U.S. 27 (1931), the
plaintiff sold a patented refrigerated transportation device that used unpatented
dry ice. Id. at 29-30. The plaintiff, who granted licenses to the patented
product only to those who purchased dry ice from it, sued another seller of dry
ice for contributory infringement. Id at 28. Relying on Motion Picture Patents,
the Court found this to be an unlawful attempt to "exact, as the condition of a
license, that unpatented materials used in connection with the invention shall be
purchased only from himself." Id. at 31. Finally, Leitch Manufacturing Co. v.
[VOL. 13: 95100
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Salt involved a manufacturer of patented machines for salt
tablets." The machines were leased to canneries for the purpose of
adding salt to canned goods." The lease included a license to use
the patented machine on the condition that licensees purchase all of
their (unpatented) salt tablets from the manufacturer's subsidiary.19
The manufacturer sued a competitor of similar machines for
infringement.20 Based on the public policy behind granting
patents,2 1 the Supreme Court held that the patentee misused the
privileges granted to it by suppressing competition outside of the
patent's scope.22 Significantly, in creating the equitable defense of
misuse, the Supreme Court expressly rejected the lower court's
conclusion that conduct could not support a misuse defense if it did
Barber Co., 302 U.S. 458 (1938), involved a manufacturer of bituminous
emulsion, a staple good used by builders of certain roads, including concrete
roads. Id. at 460. The manufacturer obtained a patent on a process for curing
concrete by spraying bituminous emulsion, and sued a competing manufacturer
for contributory infringement. Id. at 461. Citing Carbice, the Court held that it
was an unlawful attempt to restrain competition in unpatented goods. Id. at
462-63.
" Morton Salt, 314 U.S. at 489.
18 Id.
'9 Id. at 490-91.
20 id.
21 Id. at 492 ("The grant to the inventor of the special privilege of a patent
monopoly carries out a public policy adopted by the Constitution and laws of the
United States, 'to promote the Progress of Science and the useful Arts, by
securing for limited Times to ... Inventors the exclusive Right. . .' to their 'new
and useful' inventions. United States Constitution, Art. I, § 8, cl. 8; 35 U.S.C.
§ 31. But the public policy, which includes inventions within the granted
monopoly, excludes from it all that is not embraced in the invention. It equally
forbids the use of the patent to secure an exclusive right or limited monopoly not
granted by the Patent Office and which it is contrary to public policy to grant.").
22 Id. at 489-93 ("It thus appears that respondent is making use of its patent
monopoly to restrain competition in the marketing of unpatented articles, salt
tablets, for use with the patented machines, and is aiding in the creation of a
limited monopoly in the tablets not within that granted by the patent. A patent
operates to create and grant to the patentee an exclusive right to make, use and
vend the particular device described and claimed in the patent. But a patent
affords no immunity for a monopoly not within the grant, and the use of it to
suppress competition in the sale of an unpatented article may deprive the
patentee of the aid of a court of equity to restrain an alleged infringement by one
who is a competitor." (citation omitted)).
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not also violate the antitrust laws. 23 As for the remedy, the Court
deemed that the patents could not be enforced until the effects of
its' unlawful conduct were purged.24 The Court also held that the
misuse defense was available regardless of whether the party
asserting misuse was able to show harm to itself resulting from the
alleged unlawful conduct.25
23 Id. at 490 ("The Clayton Act authorizes those injured by violations tending
to monopoly to maintain suit for treble damages and for an injunction in
appropriate cases. 15 U.S.C. §§ 1, 2, 14, 15, 26. But the present suit is for
infringement of a patent. The question we must decide is not necessarily
whether respondent has. violated the Clayton Act, but whether a court of equity
will lend its aid to protect the patent monopoly when respondent is using it as
the effective means of restraining competition with its sale of an unpatented
article."); see also id. at 494 ("It is unnecessary to decide whether the
respondent has violated the Clayton Act, for we conclude that in any event the
maintenance of the present suit to restrain petitioner's manufacture or sale of the
alleged infringing machines is contrary to public policy and that the district
court rightly dismissed the complaint for want of equity.").
24 Id. It was actually in a companion case, B. B. Chemical Co. v. Ellis, 314
U.S. 495 (1942), that the Court specifically held that misuse could only be cured
by purging the effects of the conduct: "[P]etitioner suggests that it is entitled to
relief because it is now willing to give unconditional licenses to manufacturers
on a royalty basis, which it offers to do. It will be appropriate to consider
petitioner's right to relief when it is able to show that it has fully abandoned its
present method of restraining competition in the sale of unpatented articles and
that the consequences of that practice have been fully dissipated." B. B. Chem.,
314 U.S. at 497-98. B.B. Chemical involved a method patent for reinforcing
insoles in shoe manufacture. Id. at 496. The patentee licensed this patent as
well as patents on machines that it leased and used to reinforce shoe insoles. Id.
at 497. Patentee also supplied shoe manufacturers with certain unpatented
supplies used to reinforce insoles and only permitted use of the method patent
with unpatented material that it sold. Id. at 496. Patentee sued a seller of
unpatented goods for contributory infringement, and based on the same rule laid
out in Morton Salt, the Supreme Court found misuse. Id. at 497-98.
25 Morton Salt, 314 U.S. at 493-94 ("Where the patent is used as a means of
restraining competition with the patentee's sale of an unpatented product, the
successful prosecution of an infringement suit even against one who is not a
competitor in such sale is a powerful aid to the maintenance of the attempted
monopoly of the unpatented article, and is thus a contributing factor in thwarting
the public policy underlying the grant of the patent. Maintenance and
enlargement of the attempted monopoly of the unpatented article are dependent
to some extent upon persuading the public of the validity of the patent, which
the infringement suit is intended to establish. Equity may rightly withhold its
[VOL. 13: 9 5102
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The next misuse case decided by the Supreme Court was
Mercoid Corp. v. Mid-Continent Investment Co.26  Mercoid
involved a combination patent for a domestic heating system
comprised of various unpatented components. 27 The patentee set
royalties based on sales of one of the components, and licenses to
the patent were only granted when that component was used in the
system. 28 Concluding that the license was improperly used to
control the sale of unpatented components, the Court held that the
restriction constituted both misuse and an antitrust violation.29
Mercoid was controversial and ultimately resulted in legislation
limiting its application and force."
assistance from such a use of the patent by declining to entertain a suit for
infringement, and should do so at least until it is made to appear that the
improper practice has been abandoned and that the consequences of the misuse
of the patent have been dissipated .. . . It is the adverse effect upon the public
interest of a successful infringement suit, in conjunction with the patentee's
course of conduct, which disqualifies him to maintain the suit, regardless of
whether the particular defendant has suffered from the misuse of the patent."
(emphasis added)).
26 320 U.S. 661 (1944).
271 Id. at 662.
281 Id. at 664.
29 Id. at 666-67 ("The patent in question embraces furnace assemblies which
neither the patentee nor the licensee makes or vends. The struggle is not over a
combination patent and the right to make or vend it. The contest is solely over
unpatented wares which go into the patented product. Respondents point out
that the royalties under the license are measured by the number of unpatented
controls which are sold and that no royalty is paid unless a furnace covered by
the patent has been installed. But the fact remains that the competition which is
sought to be controlled is not competition in the sale of the patented assembly
but merely competition in the sale of the unpatented thermostatic controls. The
patent is employed to protect the market for a device on which no patent has
been granted. But for the patent such restraint on trade would plainly run afoul
of the anti-trust laws.").
30 There is general consensus that Section 271(d) was enacted in response to
Mercoid See, e.g., HOVENKAMP, supra note 4, at 3-5; James Kobak, A Sensible
Doctrine of Misuse for Intellectual Property Cases, 2 ALB. L.J. Scl. & TECH. I ,
11 (1992). There is much less agreement, however, over just how (and to what
extent) 271(d) altered misuse jurisprudence. Id.; see also Dawson Chem. Co. v.
Rohm & Haas Co., 448 U.S. 176, 203-12, 235-36 (1980) (White, J., dissenting)
(discussing the legislative history of the 1952 Act).
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After Mercoid, the Supreme Court's next principal misuse case
was Zenith Radio Corp. v. Hazeltine" more than two decades
later.32 Zenith Radio involved various interrelated misuse and
antitrust allegations involving patent pools and conspiracies to
deter entry in various markets." Hazeltine Corporation and its
subsidiary Hazeltine Research, Inc. (collectively referred to as
"Hazeltine") held numerous domestic patents relating to radios and
televisions.34 Hazeltine licensed many of these together in a patent
pool." Zenith manufactured radios and televisions in the United
States and had a license from Hazeltine. 6 Subsequently, Zenith
declined to renew its license, leading to an infringement action by
Hazeltine." In response, Zenith contended that Hazeltine
31 395 U.S. 100 (1969) (Though this case was later superseded by statute, in re
Recombinant DNA Tech. Patent & Contract Litigation, 850 F. Supp. 769
(1994), it remains relevant for other purposes and is still often cited in antitrust
cases today.). The Supreme Court decided three significant (if not "principal")
misuse cases prior to Zenith. First was U.S. Gypsum v. National Gypsum, 352
U.S. 457 (1957), wherein the issue was whether earlier misuse was purged. Id.
at 462. While the Court reaffirmed the misuse doctrine, it remanded the case for
factual and legal determinations concerning whether misuse was purged. Id. at
476. Second was Transparent- Wrap Machine Corp. v. Stokes & Smith, 329 U.S.
637 (1947), wherein the Court held that the grant-back license at issue was
lawful and not misuse. Id. at 646. While the Court recognized that patent pools
may be anticompetitive, it found such concerns were not applicable in the case.
Id. at 647-48. Third was Brulotte v. Thys Co., 379 U.S. 29 (1964), wherein the
Court concluded that the licensing terms being challenged, which required
royalty payments extending beyond the expiration date of all relevant patents,
was misuse. Id. at 33-34. While the Court did not hold that all royalty
payments that extend beyond expiration of all patents were misuse, the Court
believed that the facts showed it was misuse in that case, e.g., the purchase price
of each machine was a flat sum, annual payments were not part of the purchase
price but instead were royalties for use of each machine during that year, royalty
payments due for the post-expiration period were for use during that period, and
royalty payments were the same for the post-expiration period as they were for
the period of the patent. Id. at 31.
32 Zenith was not decided until 1969, fifteen years after the Supreme Court
decided Mercoid in 1944.
" Zenith, 395 U.S. at 104-05.
34 Id. at 104.
35 Id.
36 Id.
37Id.
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committed both misuse and antitrust violations by, inter alia,
conspiring with foreign manufacturers to create patent pools and
refusing to license pooled patents in certain markets for the
purpose of restraining competition." The Court concluded that, if
proven, the allegations could support both antitrust and misuse
claims.39 The Court also recognized the distinction between
antitrust and misuse:
[I]f there was such patent misuse, it does not necessarily follow that the
misuse embodies the ingredients of a violation of either § I or § 2 of
the Sherman [Antitrust] Act, or that Zenith was threatened by a
violation so as to entitle it to an injunction under § 16 of the Clayton
Act.40
B. Legislation and Dawson
In 1952, Congress amended the Patent Act ("1952 Act") and
for the first time enacted legislation on misuse.4' Rather than
defining misuse or providing substantive guidance, the provision
on misuse-Section 271(d)-is written in the negative, delineating
conduct that does not constitute misuse. Section 271(d) provides:
No patent owner otherwise entitled to relief for infringement or
contributory infringement of a patent shall be denied relief or deemed
guilty of misuse or illegal extension of the patent right by reason of his
having done one or more of the following: (1) derived revenue from
acts which if performed by another without his consent would
constitute contributory infringement of the patent; (2) licensed or
authorized another to perform acts which if performed without his
consent would constitute contributory infringement of the patent; (3)
sought to enforce his patent rights against infringement or contributory
infringement; (4) refused to license or use any rights to the patent; or
(5) conditioned the license of any rights to the patent or the sale of the
patented product on the acquisition of a license to rights in another
SId. at 104-05.
9 Id. at 139-41.
40 Id. at 140. Zenith also challenged Hazeltine's pooling arrangement, which
it contended forced Zenith to pay royalties on a patent pool of over 500 patents,
rather than A la carte for those it wanted, and basing royalties on Zenith's sales
irrespective of which patents were used. Id. at 134-35. The Court agreed that
the royalty scheme was misuse because it had the effect of forcing payment of
royalties for numerous unwanted patents. Id. at 138-41.
41 Patent Act of 1952, Pub. L. No. 593, 66 Stat. 792 (codified at 35 U.S.C.
§ 271 (2006).
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patent or purchase of a separate product, unless, in view of the
circumstances, the patent owner has market power in the relevant
market for the patent or patented product on which the license or sale is
conditioned.42
In 1980, the Supreme Court issued its last misuse case to date,
Dawson Chemical Co. v. Rohm & Haas Co.,43 wherein the Court
interpreted Section 271(d).44 Dawson involved efforts to patent
propanil, a chemical compound long known and used.45 Because it
was discovered years before, propanil was not patentable.46
However, Rohm & Haas was successful in obtaining a method
patent for using propanil as an herbicide.47 After the patent issued,
Rohm & Haas sued a competitor, Dawson Chemical Company,
asserting that the directions on Dawson's propanil herbicide
infringed the method patent." While Dawson did not contest
infringement,49 it contended that because propanil itself was
unpatented and was not "suitable for substantial noninfringing use"
(i.e., other than as an herbicide), Rohm & Haas' refusal to license
42 35 U.S.C. § 271(d) (2006). As discussed infra, Sections 271(d)(4) and
(d)(5) were not part of the 1952 Act, but were added to the statute in 1988. See
discussion infra note 45. It is worth pointing out that the 1952 Act was drafted
substantially by Giles Rich, who would later sit on the Federal Circuit and was
critical of the misuse defense. See Giles S. Rich, Misuse, A New Frontier, 14
FED. CIR. B.J. 113 (2004) (reprinting a 1952 article wherein Judge Rich
criticizes the misuse doctrine).
43 448 U.S. 176 (1980).
44 Id. at 200-223.
41 -d. at 18 1.
46 Id. at 182.
4 71 Id. at 182-83.
481 Id. at 183.
49 Id. at 185-86. Specifically, Dawson did not contest that the directions that
accompanied its propanil read on Rohm & Haas' method patent. Id. Dawson
apparently conceded that propanil constituted "a material part of [Rohm &
Haas'] invention" and was "especially made or especially adapted for use in an
infringement of [the] patent." Id. Dawson also conceded that propanil is "not a
staple article or commodity of commerce suitable for substantial noninfringing
use" as defined under Section 27 1(c). Id
106 [VOL. 13: 95
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essentially "tied" its patent rights to sales of unpatented propanil,
which Dawson maintained was misuse. 0
In a 5-4 controversial decision, the Supreme Court sided with
Rohm & Haas." Based on its interpretation of the statute, 5 2 the
legislative history," the "juxtaposed," "antiethical," and
"interrelated" principles and underpinnings between contributory
infringement and misuse,5 4 and skepticism towards misuse," the
so Id. at 186-87. A purchaser of propanil from Rohm & Haas did not get an
express license for the patent, but rather an "implied license," so that the
purchaser was without fear of being sued for infringement. Id. at 186.
5 1 See id at 223.
52 Id. at 200-01 ("[W]e believe that the language and structure of the statute
lend significant support to Rohm & Haas' contention that, because § 271(d)
immunizes its conduct from the charge of patent misuse, it should not be barred
from seeking relief.").
" Id at 213 ("It is the consistent theme of the legislative history that the
statute was designed to accomplish a good deal more than mere clarification. It
significantly changed existing law, and the change moved in the direction of
expanding the statutory protection enjoyed by patentees."); see also id. at 221
("In this instance, as we have already stated, Congress chose a compromise
between competing policy interests. The policy of free competition runs deep in
our law. It underlies both the doctrine of patent misuse and the general principle
that the boundary of a patent monopoly is to be limited by the literal scope of the
patent claims. But the policy of stimulating invention that underlies the entire
patent system runs no less deep.").
5 Id. at 179-80 ("The doctrines of contributory infringement and patent
misuse have long and interrelated histories ... . The two concepts, contributory
infringement and patent misuse, often are juxtaposed, because both concern the
relationship between a patented invention and unpatented articles or elements
that are needed for the invention to be practiced."); id. at 197-98 ("[W]e agree
with the Court of Appeals that the concepts of contributory infringement and
patent misuse 'rest on antiethical underpinnings' . . . . Proponents of
contributory infringement defend this result on the grounds that it is necessary
for the protection of the patent right, and that the market for the unpatented
article flows from the patentee's invention. They also observe that in many
instances the article is 'unpatented' only because of the technical rules of patent
claiming, which require the placement of an invention in its context. Yet
suppression of competition in unpatented goods is precisely what the opponents
of patent misuse decry. If both the patent misuse and contributory infringement
doctrines are to coexist, then, each must have some separate sphere of operation
with which the other does not interfere.").
5 Id. at 198 ("Second, we find that the majority of cases in which the patent
misuse doctrine was developed involved undoing the damage thought to have
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majority held that Section 271(d) was intended "to cut back on the
doctrine of patent misuse."56 Specifically, the Court held that
271(d) essentially immunized "non-staple" 7 goods from misuse
liability." In contrast, the dissenting opinion read the 1952 Act,59
legislative history,6 0 and its intended purpose and effect as
continuing to support a vibrant misuse defense.' Post-Dawson,
been done by A.B. Dick. The desire to extend patent protection to control of
staple articles of commerce died slowly, and the ghost of the expansive
contributory infringement era continued to haunt the courts.").
56 Id. at 184, 200-01.
5 The Court defines "non-staple" as "a component as defined in 271(c) to
which the unlicensed sale would constitute contributory infringement." Id at
186 n.6.
58 Id. at 201 ("In our view, the provisions of § 271(d) effectively confer upon
the patentee, as a lawful adjunct of his patent rights, a limited power to exclude
others from competition in nonstaple goods. A patentee may sell a nonstaple
article himself while enjoining others from marketing that same good without
his authorization. By doing so, he is able to eliminate competitors and thereby
to control the market for that product. Moreover, his power to demand royalties
from others for the privilege of selling the nonstaple item itself implies that the
patentee may control the market for the nonstaple good, otherwise, his 'right' to
sell licenses for the marketing of the nonstaple good would be meaningless,
since no one would be willing to pay him for a superfluous authorization.").
5 Id. at 232-33 (White, J., dissenting) ("The plain language of § 271 (d)
indicates that respondent's conduct is not immunized from application of the
patent misuse doctrine. The statute merely states that respondent may (1) derive
revenue from sales of unpatented propanil, (2) license others to sell propanil,
and (3) sue unauthorized sellers of propanil. While none of these acts can be
deemed patent misuse if respondent is 'otherwise entitled to relief,' the statute
does not state that respondent may exclude all competitors from the propanil
market by refusing to license all those who do not purchase propanil from it.
This is the very conduct that constitutes patent misuse under the traditional
doctrine, thus the fact that respondent may have engaged in one or more of the
acts enumerated in § 271 (d) does not preclude its conduct from being deemed
patent misuse.").
60 Id. at 235 ("Nor does the legislative history of § 271 (d) indicate to me that
Congress intended to exempt respondent's conduct from application of the patent
misuse doctrine . . . . [T]he impetus for enactment of § 271 was this Court's
decisions in the Mercoid cases.").
61 Id. at 238 ("§ 271 overturned Mercoid and intended to arm the patentee
with the power to sue unlicensed contributory infringers selling nonstaple
components used in connection with the patented process. But I do not
understand the Committee witnesses, when pressed in the 1951 Hearings, to
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debates concerning the extent to which Section 271(d) altered
misuse continued, culminating into the Patent Misuse Reform Act
of 1988, which added Sections 271(d)(4) and (5).62
C. The Federal Circuit's Misuse Jurisprudence
The U.S. Court of Appeals for the Federal Circuit was created
in 1982, shortly after Dawson was decided.63 It has exclusive
appellate jurisdiction over patent cases.' During a span of over
twenty-five years, the Federal Circuit has been critical and even
hostile to misuse, issuing several opinions with the effect of
substantially curtailing the defense.
suggest that § 271 (d) authorized the patentee to condition the use of his process
on purchasing the unpatented material from him and to exclude from the market
all other manufacturers or sellers even though they would be willing to pay a
reasonable royalty to the patent owner."); see also id at 240 ("The Court offers
reasons of policy for its obvious extension of patent monopoly, but whether to
stimulate research and development in the chemical field it is necessary to give
patentees monopoly control over articles not covered by their patents is a
question for Congress to decide, and I would wait for that body to speak more
clearly than it has.").
62 Pub L. No. 100-703, § 201, 102 Stat. 4674, 4676 (1988) (codified at 35
U.S.C. § 271(d)(4)-(5) (2006)). Notwithstanding the 1988 Act, there continues
to be substantial debate over the purpose and effect of the 1988 Act, and on
misuse generally. While proponents of misuse argue that the 1988 Act should
be construed narrowly as only applying to the specific conduct identified in
Sections 271(d)(4) and (5), critics maintain that the 1988 Act was intended to
cabin misuse. Compare Feldman, supra note 10, at 423-24, and Kobak, supra
note 30, at 24 ("The statute only liberalizes misuse in the context of ties and
refusals to license."), and Joel Bennett, Patent Misuse: Must an Alleged
Infringer Prove an Antitrust Violation? 17 AIPLA Q.J. 1, 5-6 (1989), with
Vincent Chiappetta, Living with Patents: Insights from Patent Misuse, 15 MAR.
INTEL. PROP. L. REV 1, 22 (2011) (broadly interpreting the 1988 Act).
63 See Court Jurisdiction, U.S. CT. OF APPEALS FOR THE FED. CIRCUIT,
http://www.cafc.uscourts.gov/the-court/court-jurisdiction.html. Dawson was
decided in 1980, just two years before the Court came into existence on October
1, 1982.
64 See id. The Federal Circuit has exclusive appellate jurisdiction in patent
cases. 28 U.S.C. § 1295(a) (2006). This jurisdiction includes all patent cases in
which district court jurisdiction was based on 28 U.S.C. § 1338, including those
with antitrust counterclaims arising under 28 U.S.C. § 1337. See Xeta, Inc. v.
Atex, Inc., 852 F.2d 1280, 1282 (Fed. Cir. 1988); Argus Chem. Corp. v. Fibre
Glass-Evercoat Co., 812 F.2d 1381, 1384 (Fed. Cir. 1987).
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Windsurfing International, Inc. v. AMF Inc."5 was the Federal
Circuit's first substantive misuse case.66 Windsurfing held patents
and trademarks on windsurfing boards and required patent
licensees to agree to the validity of its trademarks."7 In litigation
against Windsurfing, a competitor alleged that several of
Windsurfing's trademarks were "generic" as defined under
trademark law, and thus requiring patent licensees to agree to their
validity constituted patent misuse.68 Finding the trademarks were
"generic," the district court agreed.69 The Federal Circuit reversed,
explaining that the competitor failed to prove that Windsurfing
enforced its rights in the marks with knowledge that they were (or
had become) generic. 0 Moreover, according to the court, license
provisions enforcing trademarks were "not uncommon," were
potentially procompetitive, and "cannot possibly restrain
competition unlawfully."" Most importantly, Windsurfing
established a new prerequisite for a party asserting a misuse
defense-demonstrating that the alleged conduct had
anticompetitive effects:
To sustain a misuse defense involving a licensing arrangement not held
to have been per se anticompetitive by the Supreme Court, a factual
determination must reveal that the overall effect of the license tends to
restrain competition unlawfully in an appropriately defined relevant
market.72
6' 782 F.2d 995 (Fed. Cir. 1986).
66 While the Federal Circuit did mention misuse in Bio-Rad Laboratories, Inc.
v. Nicolet Instrument Corp., 739 F.2d 604 (Fed. Cir. 1984), it only mentioned in
passing that it was an affirmative defense, with no substantive analysis.
67 Windsurfing, 782 F.2d at 997, 1001.
6 1 d. at 1001.
69 id.
7 0 d. at 1002.
7' Id.
72 Id. at 1001-02. A subsequent case, Senza-Gel Corp. v. Seifjhart, 803 F.2d
661 (Fed. Cir. 1986), was an infringement action for a patented process
involving a "macerator," a machine used in cutting meat for a particular
purpose. Id. at 663. In response to the infringement claim, the defendant
asserted both misuse and antitrust claims, alleging that the patentee was tying its
patented process to the lease of its unpatented machine. Id. The district court
denied summary judgment on the antitrust claims, but granted summary
judgment for misuse, finding that the machine was a staple good that could be
used for non-infringing purposes, and that the patentee committed misuse by
[VOL. 13: 95110
Princo & Patent Misuse
Next, the Federal Circuit decided Mallinckrodt v. Medipart."
Mallinckrodt involved a patented "apparatus for delivery of
radioactive or therapeutic material in aerosol mist form to the lungs
of a patient, for diagnosis and treatment of pulmonary disease."74
The apparatus, which was sold to hospitals, had a "Single Use
Only" restriction." Instead of discarding it after use, however,
hospitals sent the apparatus to defendant, which sterilized it and
sent it back for reuse." The patentee sued defendant for inducing
infringement on the part of hospitals." Although the district court
deemed the restriction unenforceable under the first sale doctrine,
the Federal Circuit reversed, holding that the restriction was not
subject to the first sale doctrine." Thereafter, relying on
Windsurfing, the Federal Circuit concluded that the restriction was
not misuse because it found the restriction to be reasonably within
the patent grant and because there was insufficient evidence of
anticompetitive effects.79 In evaluating misuse, Mallinckrodt
explicitly referenced the "rule of reason"-antitrust law's method
refusing to license the patented process without also leasing the unpatented
product. Id. The Federal Circuit affirmed, noting that a "patentee's act may
constitute misuse without rising to level of an antitrust violation." Id. Thus,
summary judgment on misuse was not inconsistent with denial of summary
judgment on antitrust. Id.
" 976 F.2d 700 (Fed. Cir. 1992).
74 Id. at 701.
7 1 Id. at 702.
76 Id.
n Id.
78 Id. at 703, 706 ("The principle of exhaustion of the patent right did not turn
a conditional sale into an unconditional one."). The first sale doctrine, also
referred to as "patent exhaustion," limits the ability of a patentee to control the
use or sale of an article that embodies its patented invention once the article has
been lawfully transferred. See, e.g., Motion Picture Patents Co. v. Universal
Film Mfg., 243 U.S. 502 (1917); see also Quanta Computer, Inc. v. LG Elecs.,
Inc., 128 S. Ct. 2109 (2008); United States v. Univis Lens Co., 316 U.S. 241
(1942). For an analysis of the first sale doctrine, see Saami Zain, Quanta Leap
or Much Ado About Nothing? An Analysis On The Effect Of Quanta vs. LG
Electronics, 20 ALB. L.J. Sci. & TECH. 67, 101-02 (2010). The Federal Circuit
recently reaffirmed Mallinckrodt. See Monsanto v. Bowman, 657 F.3d 1341,
1347 (Fed. Cir. 2011).
79 Mallinckrodt, 976 F.2d at 706, 707-08.
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for evaluating whether conduct is anticompetitive." While the
opinion was somewhat ambiguous as to whether the Court required
antitrust principles to be incorporated into misuse, shortly after, in
Virginia Panel Corp. v. Mac Panel Co., the Federal Circuit made
it clear that a rule of reason was necessary to evaluate misuse
claims.82
80 Id. at 706; see also id. at 708 ("Should the restriction be found to be
reasonably within the patent grant, i.e., that it relates to subject matter within the
scope of the patent claims, that ends the inquiry. However, should such inquiry
lead to the conclusion that there are anticompetitive effects extending beyond
the patentee's statutory right to exclude, these effects do not automatically
impeach the restriction. Anticompetitive effects that are not per se violations of
law are reviewed in accordance with the rule of reason.").
8 133 F.3d 860 (1997). Virginia Panel involved patent litigation between the
only two manufacturers of a particular type of Automatic Test Equipment "used
for the diagnostic testing of systems having thousands of electronic connections,
such as airplane black boxes." Id. at 862. In response to patent litigation, the
defendant filed several counter claims, including misuse and antitrust, asserting
that patentee engaged in various unlawful conduct in attempting to persuade the
defendant's customers to switch, including sending "cease and desist" letters,
making false allegations, and proposing exclusive dealings. Id. at 863-64.
Although a jury found for the defendant on both the misuse and antitrust claims,
the Federal Circuit reversed on the grounds that the jury failed to properly apply
misuse precedent requiring that: (i) the conduct impermissibly broaden the scope
of the patent; (ii) the conduct has anticompetitive effects, and (iii) those
anticompetitive effects must be evaluated under the rule of reason. Id. at 868-
69, 73.
82 Prior to Virginia Panel, the Federal Circuit decided B. Braun Medical, Inc.
v. Abbott Laboratories, 124 F.3d 1419 (Fed. Cir. 1997). Braun involved a
patent on a particular reflux valve that attached to an intravenous line,
permitting injections or aspirations of fluids via needleless syringe. Id. at 1421.
The valves were sold with use and resale restrictions. Id. at 1422. The patentee
sued a competitor of similar valves for infringement, who, citing the use and
resale restrictions, asserted a misuse defense. Id. A jury found non-
infringement and misuse. Id. The Federal Circuit vacated the jury's verdict and
reversed, citing Mallinckrodt for the proposition that such restrictions are
typically lawful unless they violate the rule of reason. Id. at 1426-27.
Interestingly, however, the Federal Circuit distinguished between misuse and
antitrust: "The patent misuse doctrine, born from the equitable doctrine of
unclean hands, is a method of limiting abuse of patent rights separate from the
antitrust laws." Id. at 1426. Misuse was also discussed minimally in Engle
Industries, Inc. v. Lockformer Co., 96 F.3d 1398 (Fed. Cir. 1996), which
rejected the misuse defense, holding that "royalties may be based on unpatented
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The Federal Circuit's next misuse case, C.R. Bard v. M3
Systems," involved C.R. Bard's patented biopsy gun, which was
used to take tissue samples.84 When M3 Systems marketed a
competing biopsy gun, it was sued for patent infringement." In
response, M3 Systems asserted several claims, including misuse
and antitrust.86 Central to these claims were allegations that the
gun was redesigned to thwart competitors' efforts to sell
compatible parts, which was alleged to be unlawful under both
antitrust and misuse." Although a jury returned a verdict for M3
Systems on both misuse and antitrust," the Federal Circuit
disagreed, concluding that while there was sufficient evidence to
support the antitrust verdict, there was insufficient evidence to
support the misuse verdict.89 While the Federal Circuit again
recognized antitrust and misuse as legally distinct, even
acknowledging that "[p]atent misuse is viewed as a broader wrong
than antitrust violation," it nonetheless reversed and vacated the
jury's finding of misuse.90
The Federal Circuit's most recent noteworthy misuse decisions
were two factually similar cases pertaining to patents on self-
replicating seeds: Monsanto v. McFarling9' and Monsanto v.
Scruggs.92 These cases concerned Monsanto's popular ROUNDUP
herbicide, a glyphosate herbicide that kills certain weeds, as well
components if that provides a convenient means for measuring the value of the
license." Id at 1408 (citing Automatic Radio Mfg. v. Hazeltine Research, Inc.,
339 U.S. 827 (1950) and Zenith Radio Corp. v. Hazeltine Research, Inc., 395
U.S. 100 (1969).
" 157 F.3d 1340 (Fed. Cir. 1998).84 Id at 1346.
85 Id.
86 Id.
87 Id at 1372-73, 1382. In the first generation of Bard's gun, Bard did not
design the needles, but used unpatented needles designed by a third party. Id. at
1347. It was not until the second-generation gun that Bard designed its own
needles and patented the needle/gun combination. Id. at 1347-48.
88 The jury found the patents were invalid, that Bard committed fraud on the
patent office, and that it was liable for both misuse and antitrust. Id at 1346.
89 Id. at 1372-73, 1382-83.
90d. at 1372.
9' 363 F.3d 1336 (Fed. Cir. 2004).
92 459 F.3d 1328 (Fed. Cir. 2006).
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as ROUNDUP READY genetic-modification technology, which is
used to manufacture seeds that are resistant to ROUNDUP
herbicide." Using Monsanto's patented technology results in
crops that are resistant to ROUNDUP herbicide.94 The technology
is covered by various patents, including "[a] method of producing
genetically transformed plants which are tolerant toward
glyphosate herbicide.""
The central dispute in these two cases focused on various
licensing restrictions on purchasers of ROUNDUP READY seeds.
Monsanto licensed the patented gene to seed companies to develop
herbicide-tolerant seeds, which were sold to farmers who were
required to agree to license the patented technology from
Monsanto.96 The agreements between farmers and Monsanto
restricted the former's use of the seeds in various ways, including a
prohibition against replanting second-generation seeds.97
Defendants in both cases were farmers that had purchased the
seeds, used them to grow crops, and then replanted the second-
9 McFarling, 363 F.3d at 1338.
94 Id. at 1336.
95 Id. at 1339 (citing U.S. Patent No. 5,633,435 (filed May 27, 1997)).
96 The terms of the license are as follows:
[S]eed companies obtained the right to insert the genetic trait into the
germplasm of their own seeds (which can differ from seed company to
seed company), and Monsanto receives the right to a royalty or
'technology fee' of $6.50 for every 50-pound bag of seed containing
the ROUNDUP READY technology sold by the seed company.
Id. at 1339. In addition, Monsanto "owns several subsidiary seed companies that
comprise approximately 20 percent of the market for ROUNDUP READY
soybeans." Id. The license also required manufacturers to execute licenses to
farmers, rather than execute unconditional sales of the seeds. Id.
9 For example, the 1998 version of the agreement included the following
restrictions:
To use the seed containing Monsanto gene technologies for planting a
commercial crop only in a single season[;] [t]o not supply any of this
seed to any other person or entity for planting, and to not save any crop
produced from this seed for replanting, or supply saved seed to anyone
for replanting[;] [t]o not use this seed or provide it to anyone for crop
breeding, research, generation of herbicide registration data or seed
production.
Id.
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generation seeds in violation of the license. 98  When sued for
infringement, defendants plead various claims and defenses,
including misuse and antitrust.99 Although numerous arguments
were made in support of the misuse defense, the central issue
pertained to the single-use restriction.'oo Acknowledging the novel
issues posed by self-replicating technology, the Federal Circuit
upheld the restrictions as within the scope of the patent."o' Finding
that the restriction did not unlawfully extend the patentee's rights,
the Court held that there could be no misuse.'02 Using similar
reasoning, the Court rejected antitrust liability.03
98 One significant factual difference between Scruggs and McFarling involves
these licenses. The defendants in Scruggs never signed the license agreement,
while the defendant in McFarling did. Compare Monsanto v. Scruggs, 459
F.3d, 1328, 1333 (Fed. Cir. 2006), with McFarling, 363 F.3d at 1339.
9 McFarling, 363 F.3d at 1340.
'
0 0 See id. at 1341.
101 Id. at 1342-43 ("Based on the record before us, McFarling plants and
grows the first-generation seed in an identical fashion whether he intends to sell
the second-generation seed as a commercial crop for consumption or whether he
intends to replant it. Thus, the Technology Agreement does not impose a
restriction on the use of the product purchased under license but rather imposes
a restriction on the use of the goods made by the licensed product. Our case law
has not addressed in general terms the status of such restrictions placed on goods
made by, yet not incorporating, the licensed good under the patent misuse
doctrine. However, the Technology Agreement presents a unique set of facts in
which licensing restrictions on the use of goods produced by the licensed
product are not beyond the scope of the patent grant at issue: The licensed and
patented product (the first-generation seeds) and the good made by the licensed
product (the second-generation seeds) are nearly identical copies. Thus, given
that we must presume that Monsanto's '435 patent reads on the first-generation
seeds, it also reads on the second-generation seeds. See '435 patent, col. 165, 1.
12 (claiming '[a] seed of a glyphosate-tolerant plant'). Because the '435 patent
would read on all generations of soybeans produced, we hold that the
restrictions in the Technology Agreement prohibiting the replanting of the
second generation of ROUNDUP READY soybeans do not extend Monsanto's
rights under the patent statute."); see also Scruggs, 459 F.3d at 1340-42.
102 McFarling, 363 F.3d at 1342-43.
03 Id. at 1343 ("McFarling next repackages his tying patent-misuse defense as
a tying antitrust counterclaim. However, because we have found McFarling's
allegations insufficient to present a genuine issue of material fact concerning
whether Monsanto's licensing restrictions went beyond the boundaries of its
patent grant, McFarling's antitrust counterclaim also fails.").
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A secondary misuse argument, only raised in the latter of the
seed cases, Scruggs, concerned a provision in the license that
required a grower to use ROUNDUP if a farmer chose to use any
glyphosate herbicide in connection with ROUNDUP READY
seeds.'0 4 Rather than offer a bona fide procompetitive or pro-
innovation justification for the restriction, Monsanto argued "no
harm, no foul," i.e., that at the time of the restriction, Roundup was
the only glyphosate herbicide approved by the Environmental
Protection Agency for "over-the-top" application, and thus, the
restriction resulted in no anticompetitive effects.'O' Citing with
approval its precedent requiring a showing of anticompetitive
effects, the Federal Circuit agreed and ruled that the restriction did
not constitute misuse.'0 6 A strong dissent criticized the result,
opining that the restriction may have deterred entry and potential
competition.'
104 Scruggs, 459 F.3d at 1333.
o Id. at 1339-41. According to Monsanto, once competitors' products came
on the market, this restriction was taken out. Id.
106 Id. at 1341 ("In this case, Monsanto does not argue that it should escape a
finding of patent misuse because its contract provisions protected the public or
furthered EPA policy; rather, Monsanto's argument is that its contract
provisions lacked any anticompetitive effect because EPA's regulations
prohibited growers from using competing glyphosate herbicides for over-the-top
application. Therefore, even if growers elected to use such herbicides for over-
the-top application, they would not be legally free to use competing brands. As
the trial court noted, the record supports Monsanto's argument; Scruggs has not
pointed to any evidence to the contrary. The record shows that Monsanto's
competitors sought and obtained regulatory approval and that when they did,
Monsanto modified its contracts accordingly. In this unusual setting, the rule of
reason applies to the defense of patent misuse based on the alleged tying
arrangement, and under the rule of reason, Scruggs is required to show that the
challenged contracts had an actual adverse effect on competition . . . . Scruggs
did not do so and therefore cannot use the challenged contract provisions as a
defense against Monsanto's patent infringement claims. Therefore, Monsanto's
behavior did not constitute patent misuse." (citation omitted)).
107 Id. at 1343-44 (Dyk, J., dissenting) ("There was evidence that
manufacturers produced products that could have been used 'over the top,' and
that all that was lacking was regulatory approval. In other words, Monsanto's
tying arrangements here did no more than enforce a regulatory requirement.
Substantial competitive risks inhere in such an arrangement. Potential
competitors are potentially discouraged from seeking regulatory approval or
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III. THE PRINCO DECISION
The Federal Circuit's decision in Princo ended a long dispute
that started in the International Trade Commission ("ITC"), and
resulted in three Federal Circuit opinions.0 o The dispute began as
a complaint filed by Philips in the ITC alleging that certain
manufacturers were violating Section 337 of the Tariff Act of 1930
("Section 337")09 by importing products that infringed several of
Philips's patents, as well as patents belonging to a collaboration to
which Philips belonged (and for which it administered licensing
rights)."o The litigation involved numerous factual and legal
disputes, and as the case went back and forth between the ITC and
the Federal Circuit, various claims and legal theories were
amended and altered, making the case somewhat difficult to
understand."' Nevertheless, summarized below are the essential
facts, as set forth by the Federal Circuit opinions.
A. Background
The dispute concerned technology for recordable compact
discs ("CD-Rs") and rewritable compact discs ("CD-RWs")."12
attempting to have the regulation modified or eliminated. To the extent that
such efforts are discouraged, the proponent of the tie has succeeded in
eliminating competition. Moreover, in this connection it is highly significant
that Monsanto's grower license agreements did not simply require the use of a
government-approved herbicide; they explicitly required the use of 'Roundup
branded herbicide.' A potential herbicide competitor thus would be concerned
that, even if it secured government approval of its product, use of the approved
herbicide would still be barred under the contracts. The elimination of such
potential competition is not permissible under the antitrust laws.").
08 In addition, a related action was filed in the Southern District of New
York, U.S. Philips v. Princo Corp. and Princo America Corp., Civil Action No.
02-0246 (S.D.N.Y.), which was stayed pending resolution of certain issues by
the Federal Circuit pursuant to 28 U.S.C. § 1659 (1994) and an order granting
Princo's writ of mandamus.
.09 19 U.S.C. § 1337 (2006).
"o Princo Corp. v. Int'l Trade Comm'n, 616 F.3d 1318, 1323 (2010).
.. See id. at 1322-26 (discussing the procedural history and various claims of
the case between the ITC and the Federal Circuit); see also infra Part I1I.B-C
(discussing the focal dispute regarding patent misuse between the ITC and the
Federal Circuit).
112 Princo, 616 F.3d at 1322.
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While audio and read-only compact discs ("CDs") were
commercialized in the 1970s and 1980s, discs that were recordable
and rewritable, as well as compatible with prior generations of CD
players, were not developed until the mid-1990s."I The endeavor
to create CD-R/RW technology was done by a handful of firms,
led by Philips and Sony.114
Numerous technical issues needed to be solved during the
creation of the CD-R/RW technology. Relevant for the purpose of
the litigation was the particular problem of how to encode position
information onto CD-R/RW discs so that the CD player could
maintain proper positioning while writing data to the disc."'
"Philips and Sony proposed different solutions to that problem."'l 6
Philips proposed an analog method, which encoded the position
data by modulating the frequency of the "groove" on the disc to
add location codes to the disc."' Philips later disclosed this
"3 Id.
114 Id. The other firms involved were Taiyo Yuden, Yamaha, and Ricoh. Id
at 1343 (Dyk, J., dissenting). A factual issue of considerable dispute is how
much Sony assisted in the development of the CD-R/RW technology and
technical standards for the Orange Book. While the majority found that these
were jointly developed by Sony and Philips, the dissent was more skeptical,
suggesting that it was principally Phillips. Id. at 1322 (majority opinion); id. at
1343 (Dyk, J., dissenting). In its brief to the panel, Philips notes that although
Princo argued that Sony contributed very little to the creation of the CD-R/RW
technology, both the AU and the ITC found otherwise. See Brief for Intervenor
at 8 n.1, Princo Corp. v. Int'l Trade Comm'n, 616 F.3d 1318 (2010) (No. 337-
TA-474).
115 See Brief for Intervenor, supra note 114, at 9-n.2. ("CD-R/RW recorders
use a laser to write data onto the disc surface. The laser is guided by a spiral
'pregroove' track, which is stamped into the blank disc by the manufacturer.
The pregroove is 'wobbled' very slightly with periodic undulations. This
wobble is modulated by a frequency as a means of controlling the velocity at
which the disc rotates. The disc recorder uses a time code to determine the
laser's exact position on the disc at any particular time as it writes data to the
disc. The time codes, mapped by a table of contents incorporated into the
pregroove of the disc, are used to read the recorded data in the correct order.
The Orange Book refers to this process as storing 'Absolute Time in Pregroove'
or 'ATIP' because it is expressed in terms of the time required to scan from the
beginning of the track to that position.").
116 Princo, 616 F.3d at 1322.
" Id.
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method in two patent applications, U.S. Patent Nos. 4,999,825 and
5,023,856 (collectively, the "Raaymakers patents")."' In contrast,
Sony proposed a digital method to encode location codes into the
disc groove, subsequently disclosed in U.S. Patent No. 4, 942,565
(referred to as the "Lagadec patent")."'
After developing the CD-R/RW technology, technical
standards were established to ensure that discs made by different
manufacturers would be compatible, as well as playable, on
machines that were designed to read prior generations of discs (i.e.,
read-only).120  These standards were collected together in a
publication entitled "Recordable CD Standard," informally known
as the "Orange Book."' 2' At some point in the development of the
technology, Philips and Sony, as the two firms leading this
endeavor, agreed that in regards to creating a standard for solving
the aforementioned positioning problem, they would use the
Raaymakers (or analog) approach rather than the Lagadec (or
digital) approach.122  Philips and Sony incorporated the
Raaymakers approach into the Orange Book standard for
manufacturing CD-R/RWs.123 Thereafter, the companies created a
"patent pool" of all patents they contended were potentially or
reasonably necessary to create Orange Book compliant products.'24
The pool included a license to the Lagadec patent, despite the fact
that it was undisputed that a CD-R/RW created with the Lagadec
method would neither be Orange Book compliant nor be
1s Id.
119 Id.
120 id.
121 Id.
122 Id.
123 Id.
124 Id.; see also Princo Corp. v. Int'l Trade Comm'n, 563 F.3d 1301, 1312
(2009), rev'd on other grounds, 616 F.3d 1318 (2010) ("At the time the package
licenses at issue were executed it appeared that Lagadec reasonably might be
necessary to manufacture Orange Book compact discs."). Throughout the
course of the litigation, Princo challenged the lawfulness of the patent pool
under various grounds, including unlawful tying of essential to non-essential
patents, price fixing and price discrimination. See Princo, 616 F.3d at 1323-25
(discussing procedural history, including various claims made throughout).
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compatible with Orange Book compliant products.' 25 Throughout
the 1990s and up to the time of the litigation, Philips offered
various licenses to the pool.126
Of particular importance to the litigation was that licensees to
the patent pool were only permitted to use the patents to develop
Orange Book compliant products ("Restriction").127 According to
Princo, because the pool included the Lagadec patent, the
Restriction had the purpose and effect of prohibiting licensees
from using the Lagadec method to develop products to compete
with the Orange Book standard.128 Moreover, Princo alleged that
the Restriction was an integral part of an overall agreement
between Philips and Sony to foreclose potential competition to the
Orange Book standard ("Agreement").129
125 See Princo, 616 F.3d at 1324. The ITC determined that at the time the
pool was created, it was reasonable to place the Lagadec patent in the pool, even
though it could not be used to produce Orange Book standard products. Id.
According to the ITC, this is because Claim 6 of the patent arguably covered a
portion of the Orange Book standard, and thus it was reasonable to include it in
a patent pool intended to pool all patents necessary to create Orange Book
complaint products. Id. While Princo disputed this reasoning, the Federal
Circuit affirmed. Id. at 1325.
126 Id. at 1322. There is some dispute as to which license packages were
offered to which manufacturers during various time periods. After 2001, Philips
apparently offered additional licensing packages as well. Id. at 1322-23; see
also Brief for Intervenor, supra note 114, at 10-13 (discussing availability of
limited licenses for patents in the pool).
127 Philips denied the existence of the Restriction. Brief for Intervenor, supra
note 114, at 20-21. Nevertheless, the en banc majority concluded that "[t]he
package licenses contained a 'field of use' restriction, limiting the licensees to
using the licensed patents to produce discs according to the Orange Book
standards." Princo, 616 F.3d at 1322.
128 Princo, 616 F.3d at 1345 (Dyk, J., dissenting).
129 Id. As evidence of this, Princo asserts that Sony was substantially
compensated at about 36% of royalties, despite contributing very little to the
pool (given that Philips and Sony agreed to use the Raaymakers approach rather
than the Lagadec approach, and that the Lagadec patent was included in the pool
despite the fact that it could not be used to make Orange Book compliant
products). Id. at 1344-45 (citing J.A. 1830 (testimony of Dr. Jacques
Heemskerk)).
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B. Procedural History
In June 2002, Philips filed a Complaint with the ITC, alleging
that various companies were violating Section 337 by importing
products into the United States that infringed its patents.130 Princo
denied infringement and asserted various defenses, including
misuse."' The ITC found, inter alia, that Philips committed misuse
by requiring companies to acquire licenses to a patent pool, which
included non-essential patents (rather than A la carte).132
In September 2005, the Federal Circuit reversed the ITC
decision, finding that there were precompetitive justifications for
the pool, and that at the time the pool was created, it was
reasonable to include all the patents in the pool. 3 On remand, the
ITC dismissed Princo's remaining misuse claims, including its
contention that because the Lagadec patent could not be used to
develop Orange Book compliant products, its inclusion in the pool
was unlawful.'34  The ITC rejected as speculative Princo's
argument that the pool was an attempt by Sony and Philips to fix
prices of competing products by agreeing to foreclose
competition."' In making this determination, the ITC did not make
130 See Certain Recordable Compact Discs and Rewritable Compact Discs,
Inv. No. 337-TA-474, 2002 ITC LEXIS 381 (July 22, 2002) (Preliminary)
(Princo was not one of the 19 named defendants, but subsequently, the ALJ
permitted Princo to intervene in the litigation).
" Princo, 616 F.3d at 1323.
132 Certain Recordable Compact Discs and Rewritable Compact Discs, Inv.
No. 337-TA-474, 2002 ITC LEXIS 381 (July 22, 2002) (Preliminary); see also
Princo Corp. v. Int'l Trade Comm'n, 563 F.3d 1301, 1304 (2009), rev'd on
other grounds, 616 F.3d 1318 (2010). The ITC's misuse determination was
limited to four patents that it found were non-essential.
133 Princo, 616 F.3d at 1323-24.
134 Id. at 1324. According to the ITC, regardless of whether Philips could
justify including the Lagadec patent in the pool, its inclusion could not be
misuse. Id. Moreover, it also determined that that because Claim 6 of the
Lagadec patent arguably read on the Orange Book, it was not unreasonable to
include it in pool. Id. Alternatively, even if the Lagadec patent did not read on
the Orange Book, because the Court found that there was no evidence that it
competed with any patent in the pool, its inclusion was not anticompetitive and
thereby could not be misuse. Id.
'35 Id. at 1325 (asserting that charging a set price for all products in a pool
forecloses competition among competition products). The ITC also rejected the
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a factual finding on whether there was such an agreement, but
concluded that such an agreement would not support a finding of
misuse. 13 In April 2009, a panel of the Federal Circuit affirmed
the ITC's decision, except for the ITC's conclusion that the
Agreement and Restriction, if proven, could not constitute patent
misuse.137
C. The En Banc Princo Opinion
Sitting en banc, the Federal Circuit agreed with the ITC's
determination that Princo's allegations would not support a misuse
defense.' The opinion made two determinations that may have
wide-ranging implications for the future of misuse. First, the
argument, made by the ITC's independent investigating attorney, that the
Lagadec patent discouraged Sony from innovating to compete against the
Orange Book standard, as "speculation" and unsupported by evidence. Princo,
563 F.3d at 1314.
136 See Princo, 563 F.3d at 1313-14 ("Because the 'patents have not been
shown to be competing,' the Commission ruled, the pool royalty rate set by
Philips and its co-licensors was not 'a pricing agreement between competing
entities with respect to their competing products.' ") (quoting Texaco, Inc. v.
Dagher, 547 U.S. 1, 6 (2006); In re Certain Recordable Compact Discs &
Rewritable Compact Discs, No. 337-TA-474, slip op. at 22 (Int'l Trade Comm'n
Feb. 5, 2007)); see also Princo, 616 F.3d at 1337.
' Princo, 563 F.3d at 1317-18 ("To the extent that Philips contends that the
Lagadec technology must already have been developed to the point of
commercial viability before misuse could be found, it is incorrect. The thrust of
Princo's argument is that by agreement Lagadec was effectively suppressed; the
result of that suppression was that the technology could not become a viable
competitor. It cannot be the case that horizontal competitors can insulate
themselves from misuse liability simply by agreeing to suppress competing
technologies before they are fully developed. If that were the rule, then
patentees engaging in such suppression of potential alternative technologies
could never be called to account. In short, because standardization of
technology and the development of patent pools are likely to occur early in the
development of a given technology market, requiring stringent proof of the
destruction of future competition, with its accompanying imponderables, would
effectively immunize from misuse manufacturers who agree to suppress
competition from alternative technologies." (citation omitted)).
138 See Princo, 616 F.3d at 1321-22 ("[W]e sustain the decision of the
International Trade Commission that the doctrine of patent misuse does not bar
the intervenor, U.S. Philips Corporation, from enforcing its patents rights against
the appellants Princo Corporation and Princo America Corporation.").
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majority reasoned that while an antitrust violation involving
patents may also constitute misuse, a determination of misuse
liability may require significant additional findings of fact.'
Specifically, the opinion suggests that for an antitrust violation to
support a misuse defense, the following may be required: (i) the
exclusionary conduct (forming the basis of the antitrust violation)
must impermissibly broaden the physical or temporal scope of the
patent; (ii) the conduct must cause anticompetitive effects; 4 0 and
(iii) there must be a substantial nexus between the patent and the
antitrust violation, such as enforcement or use of the patent as part
of the exclusionary conduct.14 ' As applied in Princo, the majority
concluded that even if the Agreement and Restriction were done
for the explicit purpose of suppressing potential competition, it
would nonetheless not constitute misuse.'42 Rather, according to
the en banc majority, such conduct was at most "collateral" and
"unrelated" to the alleged antitrust violation.'4 3
Second, the majority reaffirmed and bolstered its precedent
mandating anticompetitive effects for misuse, even suggesting that
substantial evidence of anticompetitive effects may be required.'44
Specifically, the majority appears to conclude that even if the
evidence demonstrates that the Agreement was done for the
purpose of foreclosing competition to the Orange Book standard,
there could be no misuse because the evidence of potential
' Id. at 1329.
140 While one might assume that, as the basis of an antitrust violation, the
conduct could be assumed to be anticompetitive (as the dissent argues), Princo
suggests this may not be so. In particular, Princo appears to require evidence
that the conduct is anticompetitive, even in cases when antitrust law may not
require this. See discussion infra Parts IV.D.
141 Princo, 616 F.3d at 1327-28.
142 Id. at 1332-33.
143 Id.; see also id. at 1331 ("What patent misuse is about, in short, is 'patent
leverage,' i.e., the use of the patent power to impose overbroad conditions on the
use of the patent in suit that are 'not within the reach of the monopoly granted
by the Government.' What that requires, at minimum, is that the patent in suit
must 'itself significantly contribute[ ] to the practice under attack.' Patent
misuse will not be found when there is 'no connection' between the patent right
and the misconduct in question, or no 'use' of the patent." (citations omitted)).
144 Id. at 1337-38.
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foreclosure was too speculative.'45 According to the majority,
because the evidence indicated that at the time the patent pool was
created, the Lagadec patent was neither technically nor
commercially viable, there could be no foreclosure of competition,
and thus, no anticompetitive effects.'4 6 Finally, the majority
concluded that Princo failed to demonstrate that had the patent
pool not been created, Sony or potential licensees would have
developed competing technology using the Lagadec patent.147 A
harsh dissent was issued by the two judges that issued the (now
vacated) panel opinion, criticizing the majority as being overly
protective of patent holders and contrary to Supreme Court
precedent.'48
IV. ANALYSIS
While it is premature to all but speculate how the opinion will
be interpreted by lower courts, the likely effect of Princo will be to
substantially curtail the misuse defense. Only time will tell how
much it does so, and whether it truly "emasculates" the defense (as
the Princo dissent claims).149 If applied expansively, however, the
en banc opinion may have the effect of making it extremely
45 Id.
146 Id.
147 Id. at 1338; see also id. at 1329 ("Recognizing the narrow scope of the
doctrine, we have emphasized that the defense of patent misuse is not available
to a presumptive infringer simply because a patentee engages in some kind of
wrongful commercial conduct, even conduct that may have anticompetitive
effects.").
148 Id. at 1342 (Dyk, J., dissenting) ("Evidently the majority thinks it
appropriate to emasculate the doctrine so that it will not provide a meaningful
obstacle to patent enforcement. Outside of unlawful tying arrangements and
agreements extending the patent term, the majority would hold that antitrust
violations are not patent misuse and would leave to private and government
antitrust proceedings the task of preventing abuse of patent monopolies,
enforcement that is likely inadequate to the task. Indeed, the majority goes so
far as to suggest that the misuse doctrine be eliminated entirely. I read the
relevant Supreme Court cases and congressional legislation as supporting a
vigorous misuse defense, clearly applicable to agreements to suppress
alternative technology. The majority cabins the doctrine in contravention of this
Supreme Court authority. I respectfully dissent." (citation omitted)).
14 9 Id. at 1342.
124 [VOL. 13: 95
Princo & Patent Misuse
difficult to successfully assert a misuse defense outside of
traditional misuse per se contexts. Moreover, the decision raises
even more questions about the relationship between misuse and
antitrust.
A. Understanding Princo: Factual, Legal, and Policy
Controversies Underlying the Decision
As with many opinions, to fully appreciate and understand
Princo, one must consider underlying issues that, while may not
have been addressed in the opinion, influenced the outcome
considerably. In Princo, central to understanding both the majority
and dissenting opinions are underlying policy, legal, and factual
issues.
1. Policy: Continued Need for a Vibrant Misuse Defense?
A significant area of dispute between the majority and dissent
in Princo appears to be differing views concerning the continued
need for an independent, robust misuse doctrine.' There has been
a longstanding debate concerning the need for an independent
misuse doctrine and its proper scope. Because misuse is
predicated on patent policy and addresses other policy issues
besides just competition, some argue that antitrust is insufficient,
thereby requiring a vibrant misuse defense."' In contrast, because
'5o Compare id. at 1333 (supporting a robust misuse defense), with id. at 1350
(Dyk, J., dissenting) (discrediting the need for a such a misuse defense).
's' Bohannan, supra note 10, at 478; Feldman, supra note 10, at 431-37;
Robert Merges, Reflections on Current Legislation Affecting Patent Misuse, 70
J. PAT. & TRADEMARK OFF. Soc'Y 793, 793-94 (1988) (arguing against relying
exclusively on the antitrust rule of reason for evaluating patent misuse); Potenza,
supra note 10, at 97-100 (stating antitrust rule of reason is a starting place but
not sufficient); see also Bennett, supra note 62, at 19 (arguing that Supreme
Court decisions and the 1988 Act leave a vibrant and distinct misuse doctrine);
Richard Calkins, Patent Law: The Impact of the 1988 Patent Misuse Act and
Noerr-Pennington Doctrine on Misuse Defenses and Antitrust Counterclaims,
38 DRAKE L. REV. 175, 187 (1989) ("The strongest argument which can be
made for refusing to treat patent misuse and the antitrust laws as coterminous is
based on the underlying policies of each. The antitrust laws are intended to
foreclose unreasonable restraints of trade and illegal monopolies, and
perpetrators are severely punished for violating those laws. The 'policy
underlying the misuse doctrine is designed to prevent a patentee from projecting
FALL 2011] 125
N.C. J.L. & TECH.
the doctrine is ambiguous and because conduct traditionally found
to be misuse has often been found to violate antitrust as well,
others support limiting or even abolishing the misuse defense.'52
This policy tension is apparent in the Princo opinions, where the
dissent agrees with the view supporting a "vigorous" misuse
defense,'53 and the majority favors the latter, more skeptical
view.54
the economic effect of his admittedly valid grant beyond the limits of his legal
monopoly.' Such an economic effect can occur regardless of whether the
defendant in a patent infringement action is injured or a monopoly in trade and
commerce results. The full weight of the antitrust laws is not required to carry
out that policy." (footnote omitted)).
152 See HOVENKAMP, supra note 4, at § 3.2d, § 21.3f (arguing that "[g]enerally
speaking, patent misuse doctrine is largely coextensive with antitrust" although
may be useful to pursue "marginally anticompetitive" conduct); Chiappetta,
supra note 62, at 58 (2011) (arguing that misuse should be eliminated); Thomas
Cotter, Misuse, 44 Hous. L. REV. 901, 903, 934-38 (2007-2008) (arguing for a
"limited" misuse doctrine, to essentially fill in the gaps of antitrust where there
is speculative harm to competition); Kobak, supra note 30, at 35-44 (criticizing
the broad standing rule for misuse and proposing to allow certain procompetitive
justifications in responding to misuse allegations); Mark Lemley, The Economic
Irrationality of the Patent Misuse Doctrine, 78 CALIF. L. REv. 1599, 1620
(1990) (discussing the lack of "utility" of the misuse doctrine).
153 See Princo, 616 F.3d at 1350 (Dyk, J., dissenting) ("The antitrust laws also
provide no adequate remedy for the suppression of competition. Private
enforcement of the antitrust laws in this context is virtually impossible.
Potential purchasers of the alternative product have no remedy. The ability of
even a competitor to sue for damages is highly problematic given the early stage
of development of the Lagadec technology. And injunctive relief at the request
of a competitor is unlikely to take effect in a time frame that would allow for the
development of an alternative technology given likely litigation delays. The
difficulty of securing a misuse determination with respect to the suppressed
patent or traditional antitrust relief underscores the importance of applying the
doctrine of patent misuse to the protected patents. Unless the protected patents
are held unenforceable, there will be no adverse consequence to the patent
holder for its misconduct nor will the patent misuse be remedied." (footnote
omitted)); see also id. at 1342 ("1 read the relevant Supreme Court cases and
congressional legislation as supporting a vigorous misuse defense . . . .").
1' See id. at 1333 n.6 (majority opinion) ("The dissenters argue that antitrust
law is not adequate to protect victims of anticompetitive conduct by patentees
and that the doctrine of patent misuse must be interpreted expansively to fill that
gap. Antitrust law, however, provides robust remedies including both public
and private enforcement. An accused infringer can raise a Sherman Act claim as
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2. Law: Effect of the 1988 Act
Not unlike the controversy that surrounded the 1952 Act, there
continues to be significant dispute over the purpose and effect of
the 1988 Act: some assert that it broadly supports incorporating
antitrust analysis into misuse jurisprudence, while others read the
statute narrowly to only impose antitrust analysis to conduct
specifically delineated in the statute.'15  As is evident from the
Princo opinions, the majority favors a more expansive
interpretation of the legislation,5 6 while the dissent favors a
narrower view.' Given Federal Circuit case law, its views on the
effects of the 1988 Act on misuse are not particularly surprising.
Nevertheless, it is somewhat inconsistent with the Court's own
post-1988 Act cases, which recognize that patent misuse and
antitrust are distinct.'58
a counterclaim in an infringement action or as an affirmative claim, and is
eligible for treble damages and attorney's fees. As to the' doctrinal limitations
that apply to antitrust plaintiffs generally, such as the standing requirement,
there is no reason to believe those limitations are inappropriate simply because a
party is seeking relief against a patentee.").
15 See supra note 62 (discussing the 1988 Act).
156 See Princo, 616 F.3d at 1329-30 ("Importantly, Congress enacted section
271(d) not to broaden the doctrine of patent misuse, but to cabin it. The 1988
amendment in particular was designed to confine patent misuse, with respect to
certain licensing practices, to conduct having anticompetitive effects." (citations
omitted)).
' See id. at 1350-51 (Dyk, J., dissenting) ("Contrary to the majority, the
enactment of amendments to 35 U.S.C. § 271 in 1988 does not support the
majority's position. While the majority is correct that the legislation was
designed to cabin the misuse doctrine, it did so only by making clear that some
practices that did not constitute antitrust violations did not amount to misuse.
The legislation did not remotely suggest that antitrust violations did not
constitute misuse." (footnote omitted)); see also id at 1351 (discussing remarks
by Congressman Kastenmeir on the purpose of the 1988 Act).
158 See Monsanto Co. v. Scruggs, 459 F.3d 1328, 1339 (Fed. Cir. 2006)
("Patent misuse may be found even where there is no antitrust violation, because
'[p]atent misuse is ... a broader wrong than [an] antitrust violation."' (citing
C.R. Bard, Inc. v. M3 Sys., Inc., 157 F.3d, 1340, 1372 (Fed. Cir. 1998))); B.
Braun Med., Inc. v. Abbott Labs., 124 F.3d 1419, 1426 (Fed. Cir. 1997) (Patent
misuse is a separate "method of limiting abuse of patent rights separate from
antirust law[]."); Virginia Panel Corp. v. Mac Panel Co., 133 F.3d 860, 872
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3. Facts: Procompetitive or Naked Restraint?
The most glaring factual dispute between the majority and the
dissenting opinions in Princo was how the pooling arrangement
was viewed.'" According to the majority, it was a legitimate,
efficient means of solving a common problem and developing and
commercializing new standards.'60 Similarly, the majority found
that the Restriction was a procompetitive ancillary restraint.'"' In
contrast, the dissent (and panel) considered the Restriction to be
tantamount to an agreement not to compete, with little
procompetitive justification.'6 2 Concluding that it was at best
"inherently suspect," if not an outright naked restraint, the dissent
did not even believe a thorough evaluation of the Restriction was
necessary.'6 3 Moreover, the dissent considered as pure fantasy the
(Fed. Cir. 1997) ("[V]iolation of the antitrust laws ... requires more exacting
proof than suffices to demonstrate patent misuse.").
159 The differing factual views between the panel and en banc opinion
concerning the purpose and effect of the pooling arrangement is somewhat
similar to the differing views concerning joint ventures between Texaco, Inc.
and Shell Oil Co. to jointly refine and market gasoline in the United States
decided by the United States Supreme Court not long ago. While the Court of
Appeals for the 9th Circuit appeared to agree with the plaintiffs that the ventures
were essentially an effort to fix prices and restrain competition (and thereby
unlawful), the Supreme Court reversed, finding that the ventures were a
legitimate efficiency-enhancing enterprise. Compare Dagher v. Saudi Refining,
Inc., 369 F.3d 1108 (2004), rev'd, 547 U.S. 1 (2006), with Texaco v. Dagher,
547 U.S. 1 (2006).
160 See Princo, 616 F.3d at 1334.
161 See id. ("Whether viewed as a matter of patent misuse or in light of general
antitrust principles, Princo's claim regarding the alleged agreement fails because
Philips and Sony acted legitimately in choosing not to compete against their own
joint venture."); see also id. at 1339 ("[A]n agreement among joint venturers not
to compete against the joint venture is not a naked restraint, because it provides
assurances that the resources invested by one joint venturer will not be
undermined or competitively exploited to the sole benefit of the other.").
162 See id. at 1352-53 (Dyk, J., dissenting).
163 Id. at 1353 ("Where an agreement is considered 'inherently suspect,' courts
apply a 'quick look' rule of reason analysis . . . . '[A]n agreement not to
compete in terms of price or output' is inherently suspect. The agreement to
suppress the Lagadec patent, a competing technology, surely falls within this
category." (citation omitted)). The panel decision (written and joined by the
dissent), went even further, suggesting that such an agreement was a naked
restraint with no procompetitive justification:
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majority's view that the Restriction was "collateral" and
"unrelated" to the patent pool.'" Rather, according to the dissent,
taking Princo's allegations as true, the Agreement and Restriction
were part of the same scheme to prevent the Lagadec patent from
being developed to compete with the Orange Book standard,' 5
thereby tainting the Raaymakers patents as well.'66
Princo contends that Philips and Sony agreed from the outset to license
Lagadec, a potential competitor to the Raaymakers pool patents, in a
way that would necessarily prevent it from ever becoming a
commercially viable alternative technology that might compete with
the Orange Book standard. The essential nature of the Lagadec patent
to the Orange Book standard cannot justify the refusal to allow it to be
licensed for non-Orange Book purposes. It is one thing to offer a
pooled license to competing technologies; it is quite another to refuse
to license the competing technologies on any other basis. In contrast to
tying arrangements, there are no benefits to be obtained from an
agreement between patent holders to forego separate licensing of
competing technologies, as counsel for Philips conceded at oral
argument.
Princo Corp. v. Int'l Trade Comm'n, 563 F.3d 1301, 1315 (Fed. Cir. 2009),
rev'd, 616 F.3d 1318 (2010) (footnote omitted) (citations omitted).
'6 Princo, 616 F.3d at 1346 (Dyk, J., dissenting).
165 Compare id. at 1332, 1334 (majority opinion), with id. at 1345-46 (Dyk,
J., dissenting).
166 See id at 1348-49 (Dyk, J., dissenting) ("What the majority ignores is that
the non-compete agreements here, as in Gypsum and the court of appeals misuse
cases, are part and parcel of the agreements governing the asserted patents (here,
the Raaymakers patents). The agreement between Philips and Sony with respect
to the suppression of the Lagadec technology appears in the same letter
agreement between Philips and Sony that provided for the pooling of their
patents, including the Raaymakers patents, and the division of royalties. The
agreement between Philips and its licensees not to use the Lagadec technology
in competition with the Raaymakers technology appears in the agreements
licensing the Raaymakers technology. The overall effect of the two agreements
was to prevent competitors from utilizing the alternative Lagadec technology
and to protect the licensed Raaymakers patents from competition with the
Lagadec technology . ... Thus, the agreement to promote the Raaymakers
patents cannot be separated from the agreement to suppress the Lagadec patent.
This misconduct renders both the Raaymakers and Lagadec patents
unenforceable." (footnotes omitted)).
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B. The Decision Suggests a Very High Threshold for Proving
Anticompetitive Effects
At first blush, given Federal Circuit misuse precedent, Princo
is not particularly surprising. Although requiring anticompetitive
effects for misuse is contrary to Supreme Court precedent, it has
been cited by Federal Circuit cases going back to Windsurfing."'
Rather, what makes Princo so startling is that it appears to
establish a very high evidentiary threshold for proving
anticompetitive effects-particularly as both the majority and
dissenting opinions assumed an agreement between Philips and
Sony to include the Lagadec patent in the pool and to restrict its
use. 168
While the dissent concluded that the Restriction and
Agreement were together sufficient evidence of anticompetitive
effects, the majority required more.1 69 According to the majority,
for Princo to have proffered sufficient evidence of anticompetitive
effects, it had to demonstrate that absent (or "but for") the
Agreement, there was a "reasonable probability" that technology
incorporating the Lagadec patent would have been developed.'
This is a difficult task to accomplish, and as the dissent
167 Windsurfing Int'l, Inc. v. AMF Inc., 782 F.2d 995, 1001-02 (Fed. Cir.
1986) ("To sustain a misuse defense involving a licensing arrangement not held
to have been per se anticompetitive by the Supreme Court, a factual
determination must reveal that the overall effect of the license tends to restrain
competition unlawfully. . . .").
168 See Princo, 616 F.3d at 1331, 1337 (majority opinion); see also id. at 1344
n.5 (Dyk, J., dissenting).
169 Id. at 1342 (Dyk, J., dissenting); see also id. at 1343 ("The majority's
second holding-that there is no misuse unless the accused infringer shows that
the technology was, or would probably have become, commercially viable-is
contrary to established patent misuse doctrine. That doctrine recognizes that
antitrust violations may constitute misuse; that a presumption of anticompetitive
effect flows from an agreement not to compete; and that the burden rests on the
patent holder to justify such an agreement. Philips did not even attempt to make
the required showing here.").
170 Specifically, the majority pointed to evidence that the Lagadec patent was
neither technologically nor commercially viable, that neither Sony nor anyone
else would have developed the Lagadec patent but for the agreement, and that
there was no demand for the Lagadec patent. Id. at 1338-39 (majority opinion).
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emphasizes, is not consistent with precedent."' Moreover,
requiring such an exacting test for misuse seems perverse. "But
for" analysis is commonly applied to calculate damages in antitrust
cases. 172 However, not even an antitrust plaintiff seeking treble
damages and an injunction is required to prove as an element of
liability that "but for" the unlawful conduct, plaintiff would not
have suffered any harm."' Rather, an antitrust plaintiff need only
demonstrate that the anticompetitive conduct was a "material
cause" of its asserted injury. 174  To require such a substantial
evidentiary showing to successfully prove an equitable defense
seems excessive and contrary to the public policy arguments set
forth in Supreme Court misuse cases.
Princo exemplifies just how bizarre and onerous it would be to
require such a showing for misuse as the majority opinion
suggests. According to the majority, even assuming that the
purpose of the Agreement and Restriction were to stifle the
development of a competing technology (a seemingly naked
restraint), for Princo to succeed on its misuse defense, it would
17 See id. at 1344 n.5 (Dyk, J., dissenting).
172 A.B.A. SEC. OF ANTITRUST LAW, PROVING ANTITRUST DAMAGES: LEGAL
AND ECONOMIC ISSUES 53 (2nd ed. 2010).
1 Specifically, while an antitrust plaintiff must show proof of injury for
liability, that does not require "but for" analysis. "Injury" is defined here to
mean harm caused by the unlawful conduct, often referred to as "injury,"
"impact," or "fact of damage" in antitrust parlance. Id. at 5. This is in contrast
to "proof of damages" which requires an antitrust plaintiff to calculate his
damages as a result of the unlawful conduct. Id. at 55-56.
174 Another way of putting it is that an antitrust plaintiff need not show that
the challenged conduct was the sole cause of its injuries. Zenith Radio Corp. v.
Hazeltine Research, Inc., 395 U.S. 100, 114 n.9 (1969); see also A.B.A. SEC. OF
ANTITRUST LAW, supra note 172, at 7-9 ("Once the plaintiff has defined its
injury, the next step is to link that injury to the asserted violation. The
prevailing test of antitrust causation is 'material cause,' expressed by some
courts in the tort language of 'substantial factor' or 'proximate cause.' It is
routinely held that the violation does not have to be the sole cause of the
asserted injury, but formulations of what it means to be 'material' vary ....
Unlawful conduct may be a material cause of an asserted injury without being
the but-for cause of the entire injury. This basic distinction is evident in the
difference between how courts address fact of damage, decided under the
material cause standard, and the amount of damages, where the but-for standard
prevails." (emphasis added) (footnotes omitted)).
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have to provide sufficient evidence that there was a "reasonable
probability" that absent the Agreement and Restriction, a
technologically and commercially viable alternative would have
been developed."' Yet, as the dissent and panel decision point out,
because of the difficulty of the task, the result may essentially
immunize liability in certain cases."' Consequently, Princo may
go beyond Scruggs' "no harm, no foul" rule, to potentially grant
patentees misuse immunity for potentially anticompetitive conduct
in cases where evidence of the anticompetitive effects may be
extremely difficult to obtain-possibly due to the success of the
very conduct being challenged.
C. The Decision May Limit Misuse to Cases When a Patent is
Directly Involved in the Challenged Conduct
Another troubling interpretation of the majority decision is that
it appears to imply that misuse be limited to cases where there is a
direct, substantial nexus between the challenged conduct and a
patent."' Princo suggests that, at a minimum, the patent must
'
7 5 Princo, 616 F.3d at 1338.
176 See Princo Corp. v. Int'l Trade Comm'n, 563 F.3d 1301, 1317-18 (Fed.
Cir. 2009), rev'd, 616 F.3d 1318 (2010) ("The thrust of Princo's argument is
that by agreement Lagadec was effectively suppressed; the result of that
suppression was that the technology could not become a viable competitor. It
cannot be the case that horizontal competitors can insulate themselves from
misuse liability simply by agreeing to suppress competing technologies before
they are fully developed. If that were the rule, then patentees engaging in such
suppression of potential alternative technologies could never be called to
account."); see also Princo, 616 F.3d at 1341-57.
"7 See Princo, 616 F.3d at 1331-33 ("Philips is not imposing restrictive
conditions on the use of the Raaymakers patents to enlarge the physical or
temporal scope of those patents. Instead, the alleged act of patent misuse that
the panel focused on was the claimed horizontal agreement between Philips and
Sony to restrict the availability of the Lagadec patent-an entirely different
patent that was never asserted in the infringement action against Princo. Even if
such an agreement were shown to exist, and even if it were shown to have
anticompetitive effects, a horizontal agreement restricting the availability of
Sony's Lagadec patent would not constitute misuse of Philips's Raaymakers
patents or any of Philips's other patents in suit."); see also id at 1333 n.5 ("The
dissent suggests in passing that the Sony-Philips agreement also constitutes
misuse of the Lagadec patent. How a patent that is not enforced can be misused
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"significantly contribute" to the challenged conduct."' While this
may be a reasonable proposition as stated, as applied, Princo
seems to require a fairly tight nexus between the patent and the
conduct-even suggesting that the patent may have to be used or
enforced."' Specifically, the majority reasoned that even if
proven, the Agreement was too "collateral" to the patents to
constitute misuse.'so Moreover, it opined that, even if the
Agreement and Restriction could somehow result in the Lagadec
patents being held unenforceable, there could be no misuse of the
Raaymakers patents because, although included in the pool, the
Lagadec patents were never used or enforced."'
Prescribing that a patent be used or enforced for misuse
liability is contrary to Supreme Court precedent. While older
Supreme Court misuse cases may not be entirely clear, they do not
is not explained, nor is it clear why misuse of the Lagadec patent should be a
defense against infringement of different patents.").
"' Id. at 1331.
79 See id. at 1331.
180 Id. at 1331, 1333 ("What [patent misuse] requires, at a minimum, is that
the patent in suit must 'itself significantly contribute[ ] to the practice under
attack.' Patent misuse will not be found when there is 'no connection' between
the patent right and the misconduct in question, or no 'use' of the patent . . . . If
the purported agreement between Philips and Sony not to license the Lagadec
technology is unlawful, that can only be under antitrust law, not patent misuse
law; nothing about that agreement, if it exists, constitutes an exploitation of the
Raaymakers patents against Philips's licensees." (citations omitted)); see also id.
at 1332 ("That [Philip-Sony] agreement might be vulnerable to challenge under
the antitrust laws, but it could not reasonably be characterized as misuse of the
Raaymakers patents.").
"8 Id at 1331 ("Philips is not imposing restrictive conditions on the use of the
Raaymakers patents to enlarge the physical or temporal scope of those patents.
Instead, the alleged act of patent misuse that the panel focused on was the
claimed horizontal agreement between Philips and Sony to restrict the
availability of the Lagadec patent-an entirely different patent that was never
asserted in the infringement action against Princo. Even if such an agreement
were shown to exist, and even if it were shown to have anticompetitive effects, a
horizontal agreement restricting the availability of Sony's Lagadec patent would
not constitute misuse of Philips's Raaymakers patents or any of Philips's other
patents in suit."); see also id. at 1333 n.5 ("How a patent that is not enforced can
be misused is not explained, nor is it clear why misuse of the Lagadec patent
should be a defense against infringement of different patents.").
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require use or enforcement of a patent as an element of misuse.
For example, Zenith involved concerted activities among
manufacturers in various countries to pool patents and refuse
licenses to the pool for the purpose of suppressing competition.182
While patents were enforced in the United States via infringement
actions, it is not clear from the opinion that those suits included
each and every patent in the pool. More importantly, the Supreme
Court's decision did not even mention the enforcement of the
patent as a significant (much less necessary) factor for purposes of
misuse or antitrust liability. Similarly, as the dissent notes, United
States v. U.S. Gypsum' involved a conspiracy between
competitors of gypsum-based products to acquire and pool patents
for the purpose of fixing prices and suppressing competition on
certain gypsum products.'84 As in Zenith, while patents were
enforced via litigation among the defendants, the litigation does
not appear to be a significant factor in the Court's decision.'
Other Supreme Court cases also support misuse liability even if a
patent is not enforced or does not directly relate to the challenged
conduct.'86
182 See supra Part II.A.
"8 333 U.S. 364 (1947).
184 Princo, 616 F.3d at 1346-47 (Dyk, J., dissenting) (discussing Gypsum). In
discussing Gypsum, while the en banc panel focuses on price fixing conspiracy
-particularly the terms in the licenses allowing U.S. Gypsum to fix the
minimum prices of certain gypsum products-the Gypsum court also found
sufficient evidence that the defendants agreed to stop manufacturing certain
("open-edge") gypsum board "in order to protect the patented board from
competition." Gypsum, 333 U.S. at 384-85, 397.
185 Although the en banc majority distinguishes Zenith and Gypsum as
antitrust cases, both cases involved misuse claims either directly or indirectly.
In Zenith, the Supreme Court, on instructions for remand, expressly stated that
depending on the factual findings, misuse may be found whether or not an
antitrust violation is found. Zenith Radio Corp. v. Hazeltine Research, Inc., 395
U.S. 100, 140 (1968). While the Gypsum decision did not directly address
misuse, in a subsequent private action before the Supreme Court, the issue was
whether misuse based on the lawful conduct found in the 1947 case was purged.
U.S. Gypsum v. Nat'l Gypsum, 352 U.S. 457 (1957). Also, as the dissent notes,
subsequent cases and leading treatises cite Gypsum as dealing with conduct that
may constitute misuse. Princo, 616 F.3d at 1347 (Dyk, J., dissenting).
186 Bennett, supra note 62, at 15-17 (citing cases to argue that "[i]t is not
necessary, to establish the defense of patent misuse, that the conduct pertain
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Mandating use or enforcement of a patent as an element of
misuse, as Princo suggests, would also be bad policy.'" While not
every wrong involving a patent will justify a finding of misuse,
limiting misuse to situations where a patent was used or enforced
would substantially dilute its effectiveness in deterring inequitable
and anticompetitive conduct involving patents. A patent may be
part of an anticompetitive and/or inequitable scheme without being
used or enforced. For example, the Princo majority rejected
misuse outright, notwithstanding at least plausible evidence
suggesting that the Agreement and Restriction were part of a per se
illegal anticompetitive scheme to suppress competition.'" While it
may be argued that in many such cases, misuse may be
unnecessary because an antitrust violation may also be proven,
there are a host of problems in relying on antitrust.' Moreover,
solely to the patent at issue. The misuse doctrine is applied even though the
abusive behavior was not directly related to the patent, but merely to the sale of
goods which were covered by the patents."); see also United States v. New
Wrinkle, 342 U.S. 371 (1952).
"' Princo, 616 F.3d at 1331-32 ("What patent misuse is about, in short, is
'patent leverage,' i.e., the use of the patent power to impose overbroad
conditions on the use of the patent in suit that are 'not within the reach of the
monopoly granted by the Government.' What that requires, at minimum, is that
the patent in suit must 'itself significantly contribute[ ] to the practice under
attack.' Patent misuse will not be found when there is 'no connection' between
the patent right and the misconduct in question, or no 'use' of the patent. In this
case, there is no such link between the putative misconduct and the Raaymakers
patents." (citations omitted)); see also id. at 1329 ("While proof of an antitrust
violation shows that the patentee has committed wrongful conduct having
anticompetitive effects, that does not establish misuse of the patent in suit unless
the conduct in question restricts the use of that patent and does so in one of the
specific ways that have been held to be outside the otherwise broad scope of the
patent grant.").
1" Id. at 1349. By "outright," I mean that the majority rejected the misuse
claims without remanding to determine whether there was sufficient evidence of
an agreement to suppress competition and whether the Restriction was part of
such an agreement.
89 For example, stricter injury and standing requirements may make asserting
an antitrust counterclaim difficult. See, e.g., Brunswick Corp. v. Pueblo Bowl-
O-Mat, 429 U.S. 477 (1977); see also Assoc. Gen. Contractors of Cal. v. Cal.
State Council of Carpenters, 459 U.S. 519 (1983) (discussing antitrust injury and
standing); Blue Shield of Va. v. McCready, 457 U.S. 465 (1982). In addition,
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relying on antitrust goes against the whole purpose and policy
behind having a separate, independent misuse defense.
D. Misuse v. Antitrust: Princo Exacerbates the Ambiguity
In patent infringement cases, misuse is commonly pleaded
alongside antitrust counterclaims. And with recent misuse cases
directly applying antitrust principles, it is not surprising that
misuse and antitrust have become somewhat befuddled, if not
"hopelessly entangled"'o or "schizophrenic." 9 ' Indeed, this may
be one reason why some have argued for making the two doctrines
coextensive, hoping that joining them may at least clarify the law.
This section summarizes how antitrust evaluates whether conduct
is anticompetitive and how courts have increasingly been applying
antitrust analysis to misuse jurisprudence.
1. Applying the Rule ofReason to Misuse Cases
The purpose of the antitrust laws is to protect competition and
consumers.'9 2 The Sherman Act'93 is the cornerstone of these laws
and has been evaluating whether conduct is anticompetitive for
well over a hundred years. It proscribes both agreements that
"unreasonably" restrain trade'94 and "monopolization.""' In
antitrust counterclaims cannot be brought in Section 337 actions before the ITC.
19 U.S.C. § 1337(c).
190 Feldman, supra note 10, at 399.
191 Cotter, supra note 152, at 932.
192 See supra Part II.
193 15 U.S.C. § 1.
194 Section 1 of the Sherman Act prohibits certain joint conduct that harms
competition, providing in part: "Every contract, combination in the form of trust
or otherwise, or conspiracy, in restraint of trade or commerce among the several
States, or with foreign nations, is declared to be illegal." Despite its broad,
prohibitive terms, it has long been held that Section 1 only condemns
"unreasonable" restraints. See, e.g., Standard Oil Co. of N.J. v. United States,
221 U.S. 1 (1910).
195 Section 2 of the Sherman Act provides in part: "Every person who shall
monopolize, or attempt to monopolize, or combine or conspire with any other
person or persons, to monopolize any part of the trade or commerce among the
several States, or with foreign nations, shall be deemed guilty of a felony . . . ."
Monopolization has two elements: "1) the possession of monopoly power in the
relevant market and 2) the willful acquisition or maintenance of that power as
distinguished from growth or development as a consequence of a superior
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examining whether conduct is "unreasonable" for antitrust
purposes, courts typically determine whether the challenged
conduct is on the whole anticompetitive, by evaluating and
balancing all anticompetitive effects against procompetitive
justifications.' Because this analysis, referred to as the "rule of
reason" in antitrust parlance, is extensive and often very time
consuming, courts have articulated circumstances when the
analysis may be truncated or even obviated.' In the context of a
joint venture, it may be necessary to apply this analysis to specific
restrictions or conduct as well as to the joint venture as a whole.'9 8
product, business acumen, or historic accident." United States v. Grinnell Corp.,
384 U.S. 563, 570-71 (1966).
196 The classic description of this analysis is provided in Board of Trade of the
City of Chicago v. United States, 246 U.S. 231, 238 (1918):
The true test of legality is whether the restraint imposed is such as
merely regulates and perhaps thereby promotes competition or whether
it is such as may suppress or even destroy competition. To determine
that question the court must ordinarily consider the facts peculiar to the
business to which the restraint is applied; its condition before and after
the restraint was imposed; the nature of the restraint and its effect,
actual or probable. The history of the restraint, the evil believed to
exist, the reason for adopting the particular remedy, the purpose or end
sought to be attained, are all relevant facts.
Id.
197 For example, it has long been held that certain types of conduct are
believed to be so likely to be harmful to competition and to have no significant
procompetitive benefit, that such conduct may be condemned outright and held
to be per se illegal, without any assessment of its particular effects: "[T]here are
certain agreements or practices which because of their pernicious effect on
competition and lack of any redeeming virtue are conclusively presumed to be
unreasonable and therefore illegal without any elaborate inquiry as to the precise
harm they have caused or the business excuse for their use." N. Pac. Ry. Co. v.
United States, 356 U.S. 1, 5 (1958). Alternatively, conduct that is not deemed
per se illegal, but nevertheless "appears likely, absent an efficiency justification,
to restrict competition and decrease output," may be presumed to be
"unreasonable" without an extensive analysis, although the presumption is
rebuttable upon plausible and legally cognizable pro-competitive justification(s).
Polygram Holding Inc. v. FTC, 416 F.3d 29, 32-33 (D.C. Cir. 2005). This type
of analysis is generally termed a "quick look" analysis. See Cal. Dental Ass'n v.
FTC, 526 U.S. 756 (1998); FTC v. Ind. Fed'n of Dentists, 476 U.S. 447 (1986).
198 Given their potential for both procompetitive and anticompetitive effects,
joint ventures have long been a difficult area for antitrust. See A.B.A. SEC. OF
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Under the rule of reason, there are two means by which one
may ascertain whether a challenged restraint is anticompetitive.
First, a plaintiff may provide direct evidence of actual
anticompetitive effects.'9 9 Second, and more common, an antitrust
plaintiff may demonstrate that the defendant has "market power"200
in a "relevant market,"20 that the restraint is likely to contribute to
ANTITRUST LAW, ANTITRUST LAW DEVELOPMENTS 433-81 (6th ed. 2007);
Saami Zain, Suppression of Innovation or Collaborative Efficiencies? An
Antitrust Analysis of a Research & Development Collaboration That Led to the
Shelving of a Promising Drug, 5 J. MARSHALL REV. INTELL. PROP. L. 348, 361-
63 (2006).
'9 Ind Fed'n of Dentists, 476 U.S. at 460-61 ("Since the purpose of the
inquiries into market definition and market power is to determine whether an
arrangement has the potential for genuine adverse effects on competition, 'proof
of actual detrimental effect, such as a reduction of output,' can obviate the need
for an inquiry into market power, which is but a 'surrogate for detrimental
effect.' "); Pepsico v. Coca-Cola, 315 F.3d 101, 107 (2d Cir. 2002); Toys "R"
Us v. FTC, 221 F.3d 928, 937 (7th Cir. 2000).
200 "Market power" has been defined as "the power to control prices or
exclude competition" or to "profitably raise prices substantially above the
competitive level." See United States v. E.I. Du Pont de Nemours & Co., 351
U.S. 377, 391 (1955); United States v. Microsoft, 253 F.3d 34, 51 (D.C. Cir.
2001). The purpose for evaluating a firm's market power is to prevent
misguided and overly aggressive antitrust enforcement that may benefit
competitors rather then consumers. That is, absent sufficient market power,
conduct will not likely have an adverse effect on competition:
Antitrust is concerned with the power of market participants to distort
the competitive process. This distortion can misallocate resources,
transfer wealth from consumers and other protected groups to market
participants with power, or stifle new entry or innovation and
commercialization. Without power, a market participant can do none
of these things but is, instead, itself subject to the discipline of
competition.
SULLIVAN & GRIMES, supra note 9, at 21.
201 Southeast Mo. Hosp. v. C.R. Bard, Inc., 642 F.3d 608, 613 (8th Cir. 2011)
(" 'Antitrust claims often rise or fall on the definition of a relevant market.' "
(citation omitted)); Behrend v. Comcast Corp., No. 10-2865, 2011 WL 3678805,
at *7 (3rd Cir. Aug. 23, 2011); see also A.B.A. SEC. OF ANTITRUST LAW,
MARKET POWER HANDBOOK 54 (2005) ("The purpose of defining a relevant
market is to identify its participant: the group of firms which impose
competitive constraints upon a particular firm or combination of firms ....
Relevant markets are defined with respect to both the products or services
included in the market and the geographic scope of competition. The relevant
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the exercise of market power (typically via increased prices or
reduced output), and that the likely anticompetitive effects of the
restraint outweigh any genuine procompetitive benefits.202
While Federal Circuit misuse cases since Windsurfing have
referenced a "rule of reason," it is not evident whether the "rule of
reason" referenced in these cases is commensurate with antitrust's
203version. Despite the same nomenclature, there may be
significant procedural and substantive distinctions. First, because
misuse is broader than antitrust and based on additional policy
considerations (other than only competition), it has been suggested
that the misuse rule of reason may be more expansive to include an
evaluation of factors not traditionally considered by antitrust.204 By
comparison, copyright misuse-which derived from patent
misuse-has not been so limited by antitrust, relying on copyright
product market includes all products that substantially constrain the pricing of
the product being studied, while the relevant geographic market includes all
geographic areas where firms are located whose output substantially constrains
the pricing of the firm (or firms) being studied.").
202 A.B.A. SEC. OF ANTITRUST LAW, MONOGRAPH No. 23, THE RULE OF
REASON 133-35 (1999); see also Ind. Fed'n of Dentists, 476 U.S. at 460
("[T]he purpose of the inquiries into market definition and market power is to
determine whether an arrangement has the potential for genuine adverse effects
on competition . . . ."); Realcomp II, Ltd. v. FTC, 635 F.3d 815, 827 (6th Cir.
2011) (rejecting assertions that the FTC must show actual adverse
anticompetitive effects of the restraint: "Applying the rule of reason, we first
look to see 'whether [the] FTC has demonstrated actual detrimental effects or
the potential for genuine adverse effects on competition.' Market power and the
anticompetitive nature of the restraint are sufficient to show the potential for
anticompetitive effects under a rule-of-reason analysis, and once this showing
has been made, Realcomp must offer procompetitive justifications." (citation
omitted) (internal quotation marks omitted)).
203 B. Braun Med., Inc. v. Abbott Labs., 124 F.3d 1419 (Fed. Cir. 1997);
Virginia Panel v. Mac Panel, 133 F.3d 860 (1997); Mallinckrodt, Inc. v.
Medipart, Inc., 976 F.2d 700 (Fed. Cir. 1992).
204 See, e.g., Potenza, supra note 10, at 99 ("[C]ases such as Mallinckrodt and
Bard and the recent ITC investigations clearly suggest that the antitrust rule of
reason analysis is but a starting point for the patent misuse rule of reason
analysis. The patent misuse rule of reason analysis uses factors that are in
addition to the factors in an antitrust rule of reason analysis, as the antitrust
analysis does not take into account the policies that are the basis of the patent
system, nor does it use factors that consider the market of innovation that the
patent system is designed to foster.").
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and first amendment principles in support of a broad, robust
copyright misuse doctrine.205 Second, are lingering questions
pertaining to the application of the misuse rule of reason. For
example, recent Federal Circuit cases appear to suggest that it is
only applied after a determination is made that the restraint both
exceeds the scope of the patent and has anticompetitive effects.206
Third, is the significance of the relevant market(s) and market
power.2 07  In antitrust, ascertaining the relevant market(s) is
typically central to determining whether there is market power, and
indeed, is often outcome determinative.20 8 Given different
underlying policies, and that misuse provides only limited
remedies, it has been argued that misuse need not be as concerned
205 See, e.g., Video Pipeline v. Buena Vista, 342 F.3d 191 (3rd Cir. 2003);
Assessment Techs. of Wis., LLC v. Wiredata, 350 F.3d 640 (7th Cir. 2003);
Practice Mgmt. Info. v. Am. Med. Ass'n, 121 F.3d 516 (9th Cir. 1997), op.
amended, 133 F.3d 1140 (9th Cir. 1998); DSC Commc'ns Corp. v. DGI Techs.,
Inc., 81 F.3d 597 (5th Cir. 1996); Lasercomb Am., Inc. v. Reynolds, 911 F.2d
970 (4th Cir. 1990); see also HOVENKAMP, supra note 4, at 3-57 ("[T]he trend
in copyright misuse has departed rather markedly from antitrust principles. In
particular, most of the cases that have found copyright misuse have done so by
asserting copyright policy, not antitrust policy, as their rationale." (footnote
omitted)). Of course, this ignores the issue of whether it is sound policy to have
such a broad, ambiguous copyright misuse doctrine.
206 See Virginia Panel, 133 F.3d at 869; Mallinckrodt, 976 F.2d at 708.
207 Kenneth J. Burchfiel, Patent Misuse and Antitrust Reform: "Blessed Be
The Tie?", 4 HARV. J.L. & TECH. 1, 101 n.618 (1991) (citing Senza-Gel as
support that misuse need not look to consumer demand in determining relevant
market).
208 A.B.A. SEC. OF ANTITRUST LAW, supra note 201, at 54 ("Relevant market
definition is in most circumstances a 'necessary predicate' to assessing a firm's
'market power' and indeed market definition is outcome determinative in many
antitrust cases. In particular, whether a firm is likely to have market power will
vary depending on the scope of the likely relevant market.").
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with such market assessments.2 09 Some have even questioned
whether market power should be a prerequisite for misuse at all.2 10
The majority in Princo focused on "the market for 'licensing of
United States patents essential for production and/or sale of CD-R
and CD-RW discs, respectively.' "211 In concluding that there were
no anticompetitive effects of either the pooling arrangement, the
Agreement, or the Restriction, the Court appeared to be concerned
primarily with this market.212 However, an antitrust rule of reason
will often evaluate the effects of a licensing restraint in various
markets, particularly in "technology markets" 213 and "innovation
209 Burchfiel, supra note 207, at 101 n.619 (discussing market power analysis
in patent misuse cases, and noting that it need not be same as in antitrust);
Feldman, supra note 10, at 438; Kobak, supra note 30, at 45 (arguing that the
burden on showing market power should be on patentee); James Kobak, The
Misuse Defense and Intellectual Property Litigation, 1 B.U. J. Scl. & TECH. L. 2
para. 19 (1995) (claiming the standard for showing market power appears to be
less in misuse than antitrust).
210 Bohannan, supra note 10, at 497-500; Feldman, supra note 10, at 436.
According to these commentators, in certain scenarios, harm to innovation,
competition and/or public domain may occur absent market power, and thereby
requiring market power will immunize such conduct. See also Calkins, supra
note 151, at 187 ("The 'policy underlying the misuse doctrine is designed to
prevent a patentee from projecting the economic effect of his admittedly valid
grant beyond the limits of his legal monopoly.' Such an economic effect can
occur regardless of whether the defendant in a patent infringement action is
injured or a monopoly in trade and commerce results. The full weight of the
antitrust laws is not required to carry out that policy.").
211 Brief for Intervenor at 10, Princo Corp. v. Int'l Trade Comm'n, 616 F.3d
1318 (2010) (No. 2007-1386) (citation omitted). Because the Lagadec patent
could not be used to develop Orange Book complaint products, the majority
found that the Raaymakers and Lagadec patents were not in the same relevant
market.
212 Princo Corp. v. Int'l Trade Comm'n, 616 F.3d 1318, 1337-38 (Fed. Cir.
2010) (noting that the ITC found that the Lagadec patent does not work well
according to Orange Book standards, that there was no evidence that it was a
"commercially viable technology alternative" to the Raaymakers patents, and no
evidence that but for the patent pool, either Sony or licensees would have
developed competing technology).
213 ANTITRUST GUIDELINES, supra note 7, at 8-10 ("Technology markets
consist of the intellectual property that is licensed (the 'licensed technology')
and its close substitutes-that is, the technologies or goods that are close enough
substitutes significantly to constrain the exercise of market power with respect
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markets."21 4 For example, in addressing potential anticompetitive
concerns of licensing, the joint guidelines issued by the Federal
Trade Commission and Antitrust Division of the United States
Department of Justice evaluates harm to potential, as well as actual
competitors.215 Yet, Princo appeared to give little consideration of
competitive effects that the pooling arrangement, Agreement,
and/or Restriction may have on the market for research and
development of potential substitutes for Orange Book compliant
products. 216  Thus, at least as applied by the Princo majority, it
does not appear that the rule of reason is identical for misuse and
antitrust.
2. Anticompetitive Effects and Misuse
In rejecting the misuse defense in Princo, the Federal Circuit
relied on its own precedent mandating anticompetitive effects.2 7
While effects on competition have certainly been significant
factors in misuse cases over the years, the Supreme Court has
never made anticompetitive effects an element of misuse.
Moreover, by imposing a rule of reason analysis on misuse, this
suggests not only that anticompetitive effects are required, but that
those effects must outweigh procompetitive justifications. While
this may be appropriate for antitrust liability, it seems rather
to the intellectual property that is licensed. When rights to intellectual property
are marketed separately from the products in which they are used, the Agencies
may rely on technology markets to analyze the competitive effects of a licensing
agreement.").
214 Id. at 11 ("An innovation market consists of the research and development
directed to particular new or improved goods or processes, and the close
substitutes for that research and development. The close substitutes are research
and development efforts, technologies, and goods that significantly constrain the
exercise of market power with respect to the relevant research and development,
for example by limiting the ability and incentive of a hypothetical monopolist to
retard the pace of research and development.").
215 Id. at 6 ("Example 1").
216 See generally Brief for F.T.C. as Amicus Curiae, Princo Corp. v. Int'l
Trade Comm'n, 616 F.3d 1318 (Fed. Cir. 2010) (No. 2007-1386), 2010 WL
804423 (raising various concerns about the Federal Circuit's analysis in Princo).
To be fair, it does not appear that any party raised these issues in the ITC or on
appeal. It is also possible that there was no such market.
217 Princo, 616 F.3d at 1334.
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stringent for an equitable defense, as well as inconsistent with case
law holding that misuse is broader than antitrust. So how did the
Federal Circuit establish this prerequisite? Most likely, already
being in favor of strong patent rights, it took advantage of the
controversy surrounding the 1988 Act, and specifically, efforts to
impose antitrust analysis onto misuse. In addition, the Supreme
Court's opinion in Dawson, though a 5-4 split and far from a
model of clarity, included language evidencing skepticism of
misuse, arguably suggesting tacit approval for the Federal Circuit's
efforts to "cabin" misuse.2 8
At a more substantive level, Princo's anticompetitive effects
mandate is disconcerting and perplexing. First, it appears to
establish a very high threshold for a successful misuse defense.219
Requiring as substantial an evidentiary showing of anticompetitive
effects as Princo suggests seems contrary to the flexible nature and
purpose of the defense. Second, to the extent the result is
explained by seeking to harmonize antitrust and misuse (assuming
harmonization is desirable), it falls short even of that. As noted
supra, an antitrust violation does not always require thorough
evidence of anticompetitive effects.220 Even where substantial
evidence of anticompetitive effects is necessary, it is typically not
demonstrated via direct effects, but rather indirectly via
exclusionary conduct (such as an agreement to suppress
competition) by a firm with market power.2 2' Consequently, rather
than harmonizing these doctrines, Princo creates the rather odd
possibility that it may be more difficult to successfully assert
misuse-an equitable defense-than an affirmative treble damages
antitrust claim. By positing the existence of agreement to suppress
competition and yet nevertheless concluding that there was no
misuse, Princo makes clear that this is not just an academic,
improbable result.22 2
218 Id. at 1329-30 ("Congress enacted section 271(d) not to broaden the
doctrine of patent misuse, but to cabin it.").
219 See supra Part IV.B.
220 See supra Part IV.D.
221 Id.
222 Princo, 616 F.3d at 1333.
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V. CONCLUSION
Misuse has a long, robust history. It is based on various
worthy policy goals, including preventing inequitable, abusive, and
anticompetitive conduct by patent holders. While misuse shares
several goals and concerns with antitrust, the laws are not
coextensive. This article has put forth an argument why Princo,
and indeed all Federal Circuit misuse cases, are inconsistent with
Supreme Court precedent and bad policy. Hopefully Princo 's
holdings will be limited to the uncontroversial proposition that an
antitrust violation need not also constitute misuse, and to the
factual context of a collaborative R&D joint venture.22 3
While this article supports a vibrant misuse doctrine, it is
neither oblivious nor unsympathetic to many of the concerns and
issues raised by critics of the doctrine. Misuse lacks clear elements
and definition. It grants a great deal of discretion to courts, which
could certainly use more guidance on which types of conduct
constitute misuse as well as a better analytic framework for
evaluating misuse claims. Indeed, one reason why the Federal
Circuit may have incorporated antitrust principles into misuse is to
provide a more rigorous framework and discipline to misuse
jurisprudence. While these are valid concerns and criticisms, in
the end, not one makes an ultimately convincing argument that
misuse should be eliminated, subsumed in antitrust, or limited to
conduct traditionally found as misuse per se. Instead, this article
proposes that the legal and policy grounds for misuse are strong
enough to warrant attempting to resolve these problems rather than
throwing in the towel. As some have noted, there is a certain
amount of irony in applying the antitrust rule of reason as the
panacea for misuse.224 While the analytic framework of the rule of
223 Indeed, once the majority determined that the Restriction and pooling
arrangement were procompetitive, its conclusions as to misuse essentially
became a fait accompli. When limited to the context of a procompetitive joint
venture (as found by the majority), the conclusion becomes both narrow and
unassuming.
224 Feldman, supra note 10, at 423 (noting that Chief Judge Posner even once
remarked that the rule of reason is essentially a "euphemism for nonliability
[sic]").
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reason is relatively clear, its application is far from the model of
clarity and, indeed, has had its fair share of criticism. 225
It does not appear likely that the Supreme Court or Congress
will provide any guidance on misuse in the near future. Rather
than eviscerate the doctrine or attempt to merge it with antitrust,
however, there may be methods of modifying the doctrine to
remedy the most problematic concerns. For example, it has been
suggested that using procedural devices such as presumptions and
burdens may alleviate some of the aforementioned concerns.2 26
Another possibility may be to permit flexibility in fashioning the
appropriate remedy. Thus, a court might consider the extent of
harm, the type of harm, and whether infringement was willful. The
remedy could then vary from holding the patent unenforceable
against the world, to unenforceable against a limited group or for a
limited time period, to merely voiding a restriction. While a
flexible remedy may not be entirely consistent with Supreme Court
misuse cases, it would not be entirely contrary either. Indeed, in
Motion Picture Patents,2 27 the case generally considered the
nascent beginning of misuse, the Supreme Court merely held a
restriction void, rather than holding the patent unenforceable. A
more aggressive proposal for altering misuse has been made by
Professor Bohannan, who contends that current misuse
jurisprudence is improperly focused. Rather than focus solely on
anticompetitive effects and the scope of the patent(s) at issue, she
contends that the proper inquiry should be whether the conduct
225 See, e.g., Terry Cavali, Some Thoughts on the Rule of Reason, 2001
E.C.L.R. 201; Frank Easterbook, The Limits of Antitrust, 63 TEx. L. REv. 1, 9-
10 (1984) (discussing problems with the "empty" rule of reason); see also Einer
Elhauge, Defining Better Monopolization Standards, 56 STAN. L. REv. 253, 253
(2003) (criticizing the "vacuous standards and conclusory labels" in
monopolization's analysis of exclusionary conduct-which is similar to the rule
of reason); ANTITRUST MODERNIZATION COMMISSION, REPORT AND
RECOMMENDATIONS 91-94 (2007) (discussing various proposed standards for
evaluating whether conduct is exclusionary), available at http://govinfo.library.
unt.edu/amc/report recommendation/amcfinal report.pdf.
226 Cotter, supra note 152, at 943, 946-48. Under this method, certain
conduct, such as those likely to be procompetitive or innovative, could be
presumed valid, while other conduct presumed suspect.
227 243 U.S. 502 (1917).
FALL 2011 ] 145
N.C. J.L. & TECH.
leads to foreclosure of markets, innovation, or public access
rights.228
The purpose and scope of this article is not to proffer a solution
or even proposal for amending misuse. Rather, it is to argue in
favor of a vigorous misuse doctrine that is independent of antitrust,
and to contend that the Federal Circuit's incorporation of antitrust
analysis into misuse is problematic and not the solution to the
legitimate concerns raised about the doctrine.
228 Bohannan, supra note 10, at 500 ("1 also attempt to develop a more
coherent theory of misuse based on harm to IP policy due to foreclosure or
exclusion. Under this view, IP misuse consists of practices (mainly involving
licensing) that foreclose others from (1) competing in a particular market; (2)
producing technology that they are otherwise lawfully entitled to develop (i.e.,
restraints on innovation); or (3) accessing information or technology that
rightfully belongs in the public domain. In the course of developing this theory,
I will also analyze how particular practices can raise foreclosure concerns.").
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